<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2017.00125</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Voltage-Dependent Inhibition of Glycine Receptor Channels by Niflumic Acid</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Maleeva</surname> <given-names>Galyna</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/262866/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Peiretti</surname> <given-names>Franck</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhorov</surname> <given-names>Boris S.</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/234584/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Bregestovski</surname> <given-names>Piotr</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/6213/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>INSERM, INS, Institut de Neurosciences des Syst&#x000E8;mes, Aix-Marseille University</institution> <country>Marseille, France</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Cytology, Bogomoletz Institute of Physiology</institution> <country>Kyiv, Ukraine</country></aff>
<aff id="aff3"><sup>3</sup><institution>INSERM 1062, INRA 1260, NORT, Aix-Marseille University</institution> <country>Marseille, France</country></aff>
<aff id="aff4"><sup>4</sup><institution>Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences</institution> <country>St. Petersburg, Russia</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Biochemistry and Biomedical Sciences, McMaster University</institution> <country>Hamilton, ON, Canada</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Physiology, Kazan State Medical University</institution> <country>Kazan, Russia</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Jochen C. Meier, Technische Universitat Braunschweig, Germany</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Marcus Semtner, Max Delbr&#x000FC;ck Center for Molecular Medicine (HZ), Germany; Hans-Georg Breitinger, German University in Cairo, Egypt</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Piotr Bregestovski <email>pbreges&#x00040;gmail.com</email>; <email>piotr.bregestovski&#x00040;univ-amu.fr</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>05</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>10</volume>
<elocation-id>125</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>02</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>04</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Maleeva, Peiretti, Zhorov and Bregestovski.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Maleeva, Peiretti, Zhorov and Bregestovski</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>Niflumic acid (NFA) is a member of the fenamate class of nonsteroidal anti-inflammatory drugs. This compound and its derivatives are used worldwide clinically for the relief of chronic and acute pain. NFA is also a commonly used blocker of voltage-gated chloride channels. Here we present evidence that NFA is an efficient blocker of chloride-permeable glycine receptors (GlyRs) with subunit heterogeneity of action. Using the whole-cell configuration of patch-clamp recordings and molecular modeling, we analyzed the action of NFA on homomeric &#x003B1;1&#x00394;Ins, &#x003B1;2B, &#x003B1;3L, and heteromeric &#x003B1;1&#x003B2; and &#x003B1;2&#x003B2; GlyRs expressed in CHO cells. NFA inhibited glycine-induced currents in a voltage-dependent manner and its blocking potency in &#x003B1;2 and &#x003B1;3 GlyRs was higher than that in &#x003B1;1 GlyR. The Woodhull analysis suggests that NFA blocks &#x003B1;1 and &#x003B1;2 GlyRs at the fractional electrical distances of 0.16 and 0.65 from the external membrane surface, respectively. Thus, NFA binding site in &#x003B1;1 GlyR is closer to the external part of the membrane, while in &#x003B1;2 GlyR it is significantly deeper in the pore. Mutation G254A at the cytoplasmic part of the &#x003B1;1 GlyR pore-lining TM2 helix (level 2&#x02032;) increased the NFA blocking potency, while incorporation of the &#x003B2; subunit did not have a significant effect. The Hill plot analysis suggests that &#x003B1;1 and &#x003B1;2 GlyRs are preferably blocked by two and one NFA molecules, respectively. Molecular modeling using Monte Carlo energy minimizations provides the structural rationale for the experimental data and proposes more than one interaction site along the pore where NFA can suppress the ion permeation.</p></abstract>
<kwd-group>
<kwd>chloride-permeable channels</kwd>
<kwd>patch-clamp recordings</kwd>
<kwd>cys-loop receptors</kwd>
<kwd>Woodhull analysis</kwd>
<kwd>Monte Carlo energy minimizations</kwd>
</kwd-group>
<counts>
<fig-count count="10"/>
<table-count count="2"/>
<equation-count count="2"/>
<ref-count count="80"/>
<page-count count="17"/>
<word-count count="12336"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>The main inhibitory drive in mammalian CNS is provided by chloride (Cl<sup>&#x02212;</sup>)-permeable GABA<sub>A</sub>- and glycine receptors (GlyRs) (Sigel and Steinmann, <xref ref-type="bibr" rid="B66">2012</xref>; Lynagh and Pless, <xref ref-type="bibr" rid="B37">2014</xref>). These transmembrane proteins belong to the superfamily of pentameric Cys-loop ligand-gated channels, which also includes cation-selective nicotinic acetylcholine receptor and serotonin type3 receptor (Betz, <xref ref-type="bibr" rid="B3">1990</xref>; Miller and Smart, <xref ref-type="bibr" rid="B47">2010</xref>). GlyRs are predominantly expressed in the spinal cord (Young and Snyder, <xref ref-type="bibr" rid="B76">1973</xref>), in the brain stem (Frostholm and Rotter, <xref ref-type="bibr" rid="B17">1985</xref>; Probst et al., <xref ref-type="bibr" rid="B56">1986</xref>), cerebellum (Garcia-Alcocer et al., <xref ref-type="bibr" rid="B19">2008</xref>), other higher brain regions (Bristow et al., <xref ref-type="bibr" rid="B9">1986</xref>), and in retina (Haverkamp et al., <xref ref-type="bibr" rid="B25">2003</xref>). Functionally GlyRs participate in the movement control, perception of visual, acoustic and sensory signals and pain sensation (Harvey et al., <xref ref-type="bibr" rid="B24">2004</xref>; Betz and Laube, <xref ref-type="bibr" rid="B4">2006</xref>). Dysfunction of these receptors is associated with hyperekplexia and temporal lobe seizures accompanied by memory deficits (Lynch, <xref ref-type="bibr" rid="B40">2009</xref>; Schaefer et al., <xref ref-type="bibr" rid="B63">2012</xref>; Zuliani et al., <xref ref-type="bibr" rid="B80">2014</xref>). In the nervous system of vertebrates, molecular cloning identified four genes encoding alpha (&#x003B1;1&#x02013;&#x003B1;4) subunits and one single gene encoding beta GlyR subunits (Grenningloh et al., <xref ref-type="bibr" rid="B21">1987</xref>, <xref ref-type="bibr" rid="B22">1990</xref>; rev. Dutertre et al., <xref ref-type="bibr" rid="B16">2012</xref>). These subunits assemble to form homopentameric &#x003B1; GlyRs and heteropentameric &#x003B1;/&#x003B2; GlyRs (Lynch, <xref ref-type="bibr" rid="B39">2004</xref>).</p>
<p>Niflumic acid (NFA) (Figure <xref ref-type="fig" rid="F1">1</xref>) is a member of the fenamate class of nonsteroidal anti-inflammatory drugs originally developed for the treatment of rheumatic disorders. This drug and its derivatives are used worldwide clinically for the relief of chronic and acute pain conditions (Vincent et al., <xref ref-type="bibr" rid="B71">1999</xref>; Kang et al., <xref ref-type="bibr" rid="B31">2008</xref>; Cremonesi and Cavalieri, <xref ref-type="bibr" rid="B12">2015</xref>). As a compound with anti-inflammatory, antipyretic, and analgesic therapeutic activity, NFA has been successfully used in clinical trials in adults (Sauvage et al., <xref ref-type="bibr" rid="B62">1990</xref>; Mero et al., <xref ref-type="bibr" rid="B45">2013</xref>) and children (Manach and Ditisheim, <xref ref-type="bibr" rid="B42">1990</xref>; Lantz et al., <xref ref-type="bibr" rid="B33">1994</xref>; Sturkenboom et al., <xref ref-type="bibr" rid="B69">2005</xref>). The primary mechanism of NFA action is the inhibition of enzymes involved in the synthesis of proinflammatory prostaglandins (Smith, <xref ref-type="bibr" rid="B68">1992</xref>; McCarberg and Gibofsky, <xref ref-type="bibr" rid="B44">2012</xref>): cyclooxygenase (prostaglandin synthase) (Barnett et al., <xref ref-type="bibr" rid="B2">1994</xref>; Johnson et al., <xref ref-type="bibr" rid="B30">1995</xref>) and phospholipase A2 (PLA<sub>2</sub>) (Jabeen et al., <xref ref-type="bibr" rid="B29">2005</xref>). The structure of the complex of PLA<sub>2</sub> with NFA has been determined at the 2.5 &#x000C5; resolution revealing residues in the substrate-binding hydrophobic channel of the enzyme (Jabeen et al., <xref ref-type="bibr" rid="B29">2005</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Niflumic acid. (A)</bold> Structural formula. <bold>(B)</bold> Orthogonal views of the 3D structure. The distance between most remote atoms is 10.6 &#x000C5; and the maximal distance between van der Waals surfaces of these atoms (the maximal profile) is &#x0007E; 13 &#x000C5;.</p></caption>
<graphic xlink:href="fnmol-10-00125-g0001.tif"/>
</fig>
<p>NFA is also known as a modulator, mainly inhibitor, of different types of anion-permeable channels. However, mechanism of its action on these proteins remains unclear. NFA blocks voltage-gated chloride channels, CLC-1 (Liantonio et al., <xref ref-type="bibr" rid="B36">2007</xref>), as well as Ca<sup>2&#x0002B;</sup>-activated Cl<sup>&#x02212;</sup>- channels (CaCCs) (White and Aylwin, <xref ref-type="bibr" rid="B73">1990</xref>; Yang et al., <xref ref-type="bibr" rid="B75">2008</xref>; Huanosta-Gutierrez et al., <xref ref-type="bibr" rid="B26">2014</xref>). The effect of NFA on CaCCs is voltage-independent and it blocks the channels when applied from either outside or inside the cell (Qu and Hartzell, <xref ref-type="bibr" rid="B57">2001</xref>). A recent study demonstrated the voltage-independence of NFA action on TMEM16A-encoded CaCCs but did not determine the site of its action, suggesting the pore-blocking or/and allosteric mechanisms (Ni et al., <xref ref-type="bibr" rid="B52">2014</xref>).</p>
<p>A synthetic peptide corresponding to the TM2 transmembrane helix of GlyR forms functional ion channels in lipid bilayer, which can be blocked by NFA (Reddy et al., <xref ref-type="bibr" rid="B59">1993</xref>). However, electrophysiological analysis on cells and subunit specificity of this interaction were not performed.</p>
<p>The aim of this study was to clarify the molecular mechanism of NFA action on GlyRs. We expressed GlyRs in different subunit combinations in CHO cells and recorded glycine-induced ionic currents under NFA application using the patch-clamp technique. The NFA action at different concentrations and membrane potentials in homomeric GlyRs (formed by &#x003B1;1&#x02013;&#x003B1;3 subunits) and heteromeric GlyRs (formed by &#x003B1;1&#x003B2; or &#x003B1;2&#x003B2; subunits) were analyzed. We found that the apparent NFA affinity, the voltage-dependence and the depth of its binding in the membrane strongly depend on the GlyR subunit composition, which possess different TM2 transmembrane helices.</p>
<p>We further used molecular modeling with Monte Carlo energy minimizations to compute energy profile of NFA in the pore of &#x003B1;1 and &#x003B1;2 GlyRs. The calculations suggest that NFA can bind at more than one site within the pore. Based on our experimental data, suggesting that two and one NFA molecules block ion permeation through &#x003B1;1 GlyR and &#x003B1;2 GlyR channels, respectively, we elaborated models of NFA-bound &#x003B1;1 and &#x003B1;2 GlyRs.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Cell culture and transfection</title>
<p>The experiments were carried out on cultured Chinese hamster ovary (CHO) cells obtained from the American Type Tissue Culture Collection (ATCC, Molsheim, France) that were maintained in culture conditions as previously described (Mukhtarov et al., <xref ref-type="bibr" rid="B49">2013</xref>; Maleeva et al., <xref ref-type="bibr" rid="B41">2015</xref>).</p>
<p>For electrophysiological analysis cells were transfected with cDNAs of different subunits of glycine receptor (&#x003B1;1&#x00394;Ins, &#x003B1;2B, &#x003B1;3L, &#x003B1;1-G254A, and &#x003B2;). One day before transfection, cells were plated on the cover slips (12 mm in diameter) and placed inside 35-mm cell culture dishes with 2 ml of medium. Transfection was performed using the Lipofectamine 3000 protocol (Life Technology, USA). To facilitate identification of transfected cells a green fluorescent protein (GFP) was added to the transfection mixture. For expression of functional heteromeric receptors, cells were simultaneously transfected with cDNAs of &#x003B1; and &#x003B2; subunits in the ratio 1:10. Three hours after the initial exposure of cells to the cDNAs the culture medium was replaced with that containing strychnine (1 &#x003BC;M), which prevents spontaneous activation of GlyRs. Electrophysiological recordings were performed in the fluorescent cells 24&#x02013;72 h after transfection.</p>
</sec>
<sec>
<title>Electrophysiological recordings</title>
<p>Whole-cell and outside-out recordings were performed at room temperature (20&#x02013;25&#x000B0;C) using an EPC-9 amplifier (HEKA Elektronik, Germany). Cells were continuously superfused with external solution containing (mM): NaCl 140, CaCl<sub>2</sub> 2, KCl 2.8, MgCl<sub>2</sub> 4, HEPES 20, glucose 10; pH 7.4; 320&#x02013;330 mOsm. Intracellular solution used for filling recording patch pipettes contained (mM): CsCl 140, CaCl<sub>2</sub> 6, MgCl<sub>2</sub> 2, MgATP 2, NaGTP 0.4, HEPES/CsOH 10, BAPTA (tetrapotassium salt) 2; pH 7.3; 290 mOsm. Two different protocols of solutions application were used in this study. A &#x0201C;long protocol&#x0201D; was designed to obtain recordings of current induced by subsequent application of glycine (2 s)/glycine&#x0002B;NFA (10 s)/glycine (5 s) on the same trace; holding potential (V<sub>hold</sub>) was fixed at &#x02212;30 or &#x0002B;30 mV. A &#x0201C;ramp protocol&#x0201D; implies the gradual change of V<sub>hold</sub> alternately from &#x02212;80 to &#x0002B;80 mV and from &#x0002B;80 to &#x02212;80 mV during 1 s, V<sub>hold</sub> was fixed at &#x02212;80 or &#x0002B;80 mV at the beginning and at the end of the ramp for 500 ms (Figure <xref ref-type="fig" rid="F2">2B</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Effect of NFA on homomeric GlyRs formed by &#x003B1;1 subunits. (A)</bold> Inhibition of glycine-evoked currents (30 &#x003BC;M) by different concentrations of NFA (30, 100, 300 &#x003BC;M). Glycine was applied for 2 and 5 s at the beginning and the end of the trace respectively. In the middle of the trace, the mixture of glycine with NFA was applied (10 s). Durations of drugs applications are indicated by bars above the traces. Recordings were performed at V<sub>hold</sub> &#x0002B;30 mV (upper traces) and &#x02212;30 mV (bottom traces). <bold>(B)</bold> Scheme of the &#x0201C;ramp protocol&#x0201D; and representative traces obtained using this protocol in control (30 &#x003BC;M glycine, black) and while applying a mixture of glycine 30 &#x003BC;M and NFA 300 &#x003BC;M (orange). <bold>(C)</bold> Representative current-voltage relationships obtained during application of 30 &#x003BC;M of glycine alone (black) or mixed with different concentrations of NFA (30 &#x003BC;M-yellow, 100-blue, 300-red). <bold>(D)</bold> Representative current-voltage relationships recorded in the presence of 100 &#x003BC;M of glycine alone or mixed with different concentrations of NFA (30, 100, 300 &#x003BC;M). <bold>(E)</bold> NFA IC<sub>50</sub> at different holding potentials. Currents were evoked by application of 30 &#x003BC;M (gray columns) and 100 &#x003BC;M (green columns, <italic>n</italic> &#x0003D; 10) of glycine. Recordings were performed using the &#x0201C;ramp protocol,&#x0201D; data represented as mean &#x000B1; SEM, <sup>&#x0002A;&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.001, unpaired <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fnmol-10-00125-g0002.tif"/>
</fig>
<p>Nonsaturating and subsaturating concentrations of glycine for different subunit combinations of GlyRs were chosen according to the EC<sub>50</sub> curves obtained in previous studies. It was shown that for homomeric &#x003B1;1 GlyRs EC<sub>50</sub> varies between 25 and 40 &#x003BC;M (Zhang et al., <xref ref-type="bibr" rid="B77">2008</xref>; Lynagh et al., <xref ref-type="bibr" rid="B38">2011</xref>; Maleeva et al., <xref ref-type="bibr" rid="B41">2015</xref>), thus nonsaturating concentration of the agonist used for &#x003B1;1GlyRs was 30 &#x003BC;M, subsaturating &#x02013; 100 &#x003BC;M. For &#x003B1;2 GlyRs mean value of EC<sub>50</sub> for glycine was estimated as 42 &#x000B1; 2 &#x003BC;M (Maleeva et al., <xref ref-type="bibr" rid="B41">2015</xref>), i.e., close to that for &#x003B1;1 GlyRs, so subsaturating concentrations of glycine were the same as for &#x003B1;1 GlyRs. The sensitivity of &#x003B1;3 GlyRs to glycine is significantly lower than of &#x003B1;1 and &#x003B1;2 GlyRs, comprising 80&#x02013;150 &#x003BC;M (Zhang et al., <xref ref-type="bibr" rid="B77">2008</xref>; Maleeva et al., <xref ref-type="bibr" rid="B41">2015</xref>; S&#x000E1;nchez et al., <xref ref-type="bibr" rid="B61">2015</xref>); according to this we used 100 &#x003BC;M of glycine as nonsaturating concentration of the agonist. Sensitivity of &#x003B1;1&#x003B2; GlyRs is close to that of homomeric &#x003B1;1 GlyRs, i.e., between 25 and 50 &#x003BC;M (Rundstrom et al., <xref ref-type="bibr" rid="B60">1994</xref>; Shan et al., <xref ref-type="bibr" rid="B65">2001</xref>; Islam and Lynch, <xref ref-type="bibr" rid="B28">2012</xref>); EC<sub>50</sub> of &#x003B1;2&#x003B2; GlyRs varies between 50 and 85 &#x003BC;M (Pribilla et al., <xref ref-type="bibr" rid="B55">1992</xref>; Miller et al., <xref ref-type="bibr" rid="B46">2005</xref>; Zhang et al., <xref ref-type="bibr" rid="B77">2008</xref>). It was demonstrated previously (Shan et al., <xref ref-type="bibr" rid="B65">2001</xref>; Islam and Lynch, <xref ref-type="bibr" rid="B28">2012</xref>) and confirmed by our experiments that mutation G254A does not change sensitivity of &#x003B1;1 GlyRs to glycine.</p>
<p>Recording pipettes were pulled from borosilicate glass capillaries (Harvard Apparatus Ltd, USA) and had resistances of 5&#x02013;10 MOhm. For the rapid replacement of the solutions, the fast application system was used. Three parallel rectangular tubes (100 &#x000D7; 100 &#x003BC;m) were positioned 40&#x02013;50 &#x003BC;m above the recorded cell. The movement of the tubes was controlled by a computer-driven fast exchange system (SF 77A Perfusion Fast-Step, Warner, USA) allowing a 10&#x02013;90% solution exchange in 3&#x02013;5 ms, as measured by open electrode controls (1/10 external solution/water). Cells with low input resistance (&#x0003C;150 MOhm) and a rapid run-down (&#x0003E;30% with repetitive application) were excluded from analysis.</p>
</sec>
<sec>
<title>Drugs</title>
<p>All the drugs were obtained from Tocris or Sigma&#x02013;Aldrich (France). NFA (100 mM) and picrotoxin (50 mM) were first dissolved in DMSO and then diluted with the extracellular solution to the final concentrations. In the test experiments, DMSO itself had no effect on the glycine-induced current (data not shown; see also Mascia et al., <xref ref-type="bibr" rid="B43">1996</xref>; Hall et al., <xref ref-type="bibr" rid="B23">2004</xref>). A stock solution of glycine (1M) was prepared using MilliQ water.</p>
</sec>
<sec>
<title>Data analysis and statistics</title>
<p>Electrophysiological recordings were performed using PatchMaster (HEKA Electronic, Germany) software. To plot concentration-response curves, responses to different concentrations of glycine and NFA were fitted using a nonlinear fitting routine of the Origin 7.5 software (OriginLabs, USA) with the Hill equation:
<disp-formula id="E1"><mml:math id="M1"><mml:mtable columnalign='left'><mml:mtr><mml:mtd><mml:mtext>For&#x02009;glycine</mml:mtext><mml:mo>:</mml:mo><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mi>I</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mo>/</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mo stretchy='false'>(</mml:mo><mml:msub><mml:mrow><mml:mtext>EC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mo stretchy='false'>[</mml:mo><mml:mtext>A</mml:mtext><mml:mo stretchy='false'>]</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>H</mml:mi></mml:mrow></mml:msup><mml:mo stretchy='false'>)</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext>For&#x02009;NFA</mml:mtext><mml:mo>:</mml:mo><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mi>I</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mo>/</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mo stretchy='false'>(</mml:mo><mml:mo stretchy='false'>[</mml:mo><mml:mtext>inh</mml:mtext><mml:mo stretchy='false'>]</mml:mo><mml:msub><mml:mrow><mml:mo>/</mml:mo><mml:mtext>IC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mi>H</mml:mi></mml:mrow></mml:msup><mml:mo stretchy='false'>)</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>
where <italic>I</italic> is the normalized current amplitude induced by the agonist at concentration [A], [inh] &#x02013; concentration of NFA, <italic>Imax</italic> is a maximal current induced at given cell, <italic>n</italic><sub><italic>H</italic></sub> is the Hill coefficient and EC<sub>50</sub> or IC<sub>50</sub> are the concentrations at which a half-maximum response was induced.</p>
<p>The fractional electrical distance from the external side of the membrane (&#x003B4;) at which bound NFA blocked the current was calculated using the Woodhull equation:
<disp-formula id="E2"><mml:math id="M2"><mml:mrow><mml:msub><mml:mrow><mml:mtext>IC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub><mml:mo stretchy='false'>(</mml:mo><mml:mtext>V</mml:mtext><mml:mo stretchy='false'>)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mtext>IC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub><mml:mo stretchy='false'>(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy='false'>)</mml:mo><mml:mtext>&#x02009;exp&#x02009;</mml:mtext><mml:mo stretchy='false'>(</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mi>&#x003B4;</mml:mi><mml:mtext>FV</mml:mtext><mml:mo>/</mml:mo><mml:mtext>RT</mml:mtext><mml:mo stretchy='false'>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
where IC<sub>50</sub>(V) is IC<sub>50</sub> at the given membrane potential, IC<sub>50</sub>(0) &#x02013; at 0 mV, V &#x02013; membrane potential and F, R, T have their usual meanings. &#x003B4; was determined from a plot of IC<sub>50</sub> values against membrane potential.</p>
<p>For statistical analysis paired and unpaired <italic>t</italic>-tests were used. Data are represented as means &#x000B1; SEM.</p>
</sec>
<sec>
<title>Molecular modeling</title>
<sec>
<title>General features of the model</title>
<p>The cryo-EM structure of the open state &#x003B1;1 GlyR (Du et al., <xref ref-type="bibr" rid="B15">2015</xref>) (PDB code 3JAE) was used to create models of transmembrane parts of &#x003B1;1 and &#x003B1;2 GlyR channels and explore interactions of NFA with these models. We removed the extracellular region and focused on the central pore region, which is lined by five M2 helices. In the &#x003B1;2 GlyR model, five Gly254 residues at level 2&#x02032; were replaced with alanines. Each model also included 10 M1 and M3 helices. The 15-helix bundles of &#x003B1;1 and &#x003B1;2 GlyRs were optimized using the ZMM program (<ext-link ext-link-type="uri" xlink:href="http://www.zmmsoft.com">http://www.zmmsoft.com</ext-link>) and the Monte Carlo energy-minimization (MCM) protocol (Li and Scheraga, <xref ref-type="bibr" rid="B35">1987</xref>) as described elsewhere (Bruhova et al., <xref ref-type="bibr" rid="B10">2008</xref>; Garden and Zhorov, <xref ref-type="bibr" rid="B20">2010</xref>). Molecular images were created using the PyMol Molecular Graphics System, Version 0.99rc6 (Schr&#x000F6;dinger, LLC, New York, NY).</p>
</sec>
<sec>
<title>Niflumic acid geometry</title>
<p>In the X-ray structures of free NFA (Murthy and Vijayan, <xref ref-type="bibr" rid="B50">1978</xref>) the molecule is virtually planar. In the available X-ray structures of proteins with NFA (Jabeen et al., <xref ref-type="bibr" rid="B29">2005</xref>) (PDB codes 1TD7 and 2WM3) it is also nearly planar. We have built the ligand using a 2-fold torsional potential for the Ph-COO bond (benzoic acid) with the barrier height of 3 kcal/mol and minima at 90 and &#x02212;90&#x000B0; (Lautenschlager and Brickmann, <xref ref-type="bibr" rid="B34">1991</xref>). NFA adopted a nearly planar conformation with the intramolecular H-bond NH&#x02014;O (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
</sec>
<sec>
<title>Pulling NFA through the pore</title>
<p>The interaction energy of NFA with the channel was computed as in Bruhova and Zhorov (<xref ref-type="bibr" rid="B11">2010</xref>). We pulled NFA from the cytoplasmic side to the extracellular side of the pore starting from the level below &#x02212;2&#x02032; (Pro250) to level 20&#x02032; (Ala/Gly272) with the step of 0.5 &#x000C5;. At each step, the nitrogen atom located between two rings of NFA (N1) was constrained to the plane, which is normal to the pore axis and crosses the axis at this level. To prevent &#x0201C;escape&#x0201D; of NFA from the pore, another constraint was used that allowed atom N1 to deviate up to 6 &#x000C5; from the pore axis and imposed an energy penalty for larger deviations. At each level of the pore, the energy was MC-minimized until 100 consecutive energy minimizations did not decrease the best energy found at this level. To preclude large deviations of the model backbones from the X-ray templates and thus preserve the channel folding during docking of flexible ligand to the flexible protein, a set of distance constraints (pins), was imposed between matching alpha carbons in the X-ray structure and in the model. A pin constraint is a flat-bottom parabolic energy function that allows an atom (in this study, an alpha carbon) to deviate penalty-free up to 1 &#x000C5; from the template and imposes a penalty of 10 kcal mol<sup>&#x02212;1</sup> &#x000C5;<sup>&#x02212;1</sup> for larger deviations. The MC-minimization protocol optimized the system energy that included the penalty energy. In every MC-minimized structure, the energy of constrains was close to zero indicating that the ligand binding did not affect the protein folding in our models.</p>
</sec>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Action of niflumic acid on &#x003B1;1 GlyRs</title>
<p>The NFA ability to modulate currents in different GlyR subtypes was determined using a whole-cell configuration of patch-clamp technique. GlyRs composed of different subunits were transiently expressed in the CHO cell line. First, we have examined the effect of varying concentrations of NFA on homomeric &#x003B1;1 GlyR at constant holding membrane potentials (V<sub>hold</sub>) of &#x0002B;30 and &#x02212;30 mV using a &#x0201C;long&#x0201D; protocol of solutions application. Ionic currents were evoked by 30 &#x003BC;M of glycine alone (near EC<sub>50</sub> concentration for &#x003B1;1 and &#x003B1;2 GlyRs, Maleeva et al., <xref ref-type="bibr" rid="B41">2015</xref>) or mixed with different NFA concentrations. The inhibition was more pronounced at positive membrane potentials (Figure <xref ref-type="fig" rid="F2">2A</xref>). Thus, at V<sub>hold</sub> of &#x02212;30 mV, concentrations of NFA 30, 100 and 300 &#x003BC;M caused inhibition of &#x003B1;1GlyR-mediated currents by 3 &#x000B1; 4, 16 &#x000B1; 6, and 48 &#x000B1; 9%, respectively (<italic>n</italic> &#x0003D; 7), while at V<sub>hold</sub> of &#x0002B;30 mV currents were inhibited by 16 &#x000B1; 7, 43 &#x000B1; 11, and 75 &#x000B1; 4%, respectively (<italic>n</italic> &#x0003D; 7).</p>
<p>To examine in detail the voltage dependence of GlyR block by NFA we have used a &#x0201C;ramp&#x0201D; protocol that allowed fast changes of the membrane potential from &#x02212;80 to &#x0002B;80 mV (Figure <xref ref-type="fig" rid="F2">2B</xref>). Representative current-voltage dependence curves recorded during application of glycine alone or mixed with different concentrations of NFA are shown in Figure <xref ref-type="fig" rid="F2">2C</xref>. Glycine concentration of 30 &#x003BC;M (near EC<sub>50</sub>) produced an outwardly rectifying current due to the higher probability of the open-state &#x003B1;1 GlyR at positive potentials (Fucile et al., <xref ref-type="bibr" rid="B18">1999</xref>). While NFA exhibited rather low affinity to &#x003B1;1 GlyR, especially at negative potentials, we have revealed significant (<italic>p</italic> &#x0003C; 0.01) voltage dependence of inhibition. Figure <xref ref-type="fig" rid="F2">2E</xref> shows that at &#x02212;80 mV IC<sub>50</sub> of NFA was 315 &#x000B1; 30 &#x003BC;M, while at &#x0002B;80 mV it was 197 &#x000B1; 18 &#x003BC;M (<italic>n</italic> &#x0003D; 10). The voltage dependence of inhibition suggests that NFA acts as an open channel blocker of &#x003B1;1 GlyRs.</p>
<p>To test this hypothesis we performed the same experiment with higher, near-saturating concentration of glycine (100 &#x003BC;M) that causes longer mean open time of GlyR channels. The potency of the channel block by NFA increased, particularly at positive potentials (<italic>p</italic> &#x0003C; 0.001). IC<sub>50</sub> of NFA at &#x02212;80 mV was 270 &#x000B1; 26 &#x003BC;M, while at &#x0002B;80 mV about 3-fold decrease was observed: IC<sub>50</sub> &#x0003D; 90&#x000B1;8 &#x003BC;M (<italic>n</italic> &#x0003D; 10) (Figures <xref ref-type="fig" rid="F2">2D,E</xref>). These results provide additional support to the suggestion that NFA inhibits &#x003B1;1 GlyR currents as an open channel blocker.</p>
</sec>
<sec>
<title>Action of niflumic acid on &#x003B1;2 GlyRs</title>
<p>Analysis of NFA action on &#x003B1;2 GlyR revealed two important peculiarities. Firstly, its inhibitory activity was much higher in comparison with that on &#x003B1;1 GlyR. Secondly, the voltage-dependence of inhibition was much more profound. Using a &#x0201C;long application&#x0201D; protocol we have demonstrated that NFA concentration as small as 10 &#x003BC;M inhibited currents by &#x0007E;50% at MP of &#x0002B;30 mV (Figure <xref ref-type="fig" rid="F3">3A</xref>). The voltage dependence of &#x003B1;2 GlyR inhibition by NFA (10 &#x003BC;M) was also prominent: at MP &#x0003D; &#x02212;80 mV glycine-evoked current comprised 89 &#x000B1; 4% from the control, while at &#x0002B;80 mV it was as small as 43 &#x000B1; 5% (<italic>n</italic> &#x0003D; 5) (Figure <xref ref-type="fig" rid="F3">3B</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>Action of NFA on the &#x003B1;2 GlyR. (A)</bold> Inhibition of glycine-induced currents (30 &#x003BC;M) by different concentrations of NFA (10, 30, and 100 &#x003BC;M). V<sub>hold</sub> is &#x0002B;30 mV (upper traces) and &#x02212;30 mV (bottom traces). <bold>(B)</bold> Percentage of the current that remained under application of 10 &#x003BC;M of NFA at &#x0002B;80 and &#x02212;80 mV. Data from 5 cells. <sup>&#x0002A;&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.001, paired <italic>t</italic>-test. <bold>(C)</bold> Representative current-voltage curves obtained in the presence of 30 &#x003BC;M glycine alone or in mixture with different concentrations of NFA (10 &#x003BC;M-green, 30-yellow, 100-blue, 300-red). <bold>(D)</bold> NFA IC<sub>50</sub> at different potentials. Channels were activated by 30 &#x003BC;M (gray, <italic>n</italic> &#x0003D; 8) or 100 &#x003BC;M (green, <italic>n</italic> &#x0003D; 7) of glycine. Data represented as mean &#x000B1; SEM.</p></caption>
<graphic xlink:href="fnmol-10-00125-g0003.tif"/>
</fig>
<p>To study in detail the voltage dependence of &#x003B1;2 GlyR block by NFA, we have used the same &#x0201C;ramp&#x0201D; protocol as we did for &#x003B1;1 GlyR. Unlike in &#x003B1;1 GlyRs, activation of &#x003B1;2 GlyRs by nonsaturating agonist concentration (30 &#x003BC;M) produced inwardly rectifying currents, suggesting that the open probability of &#x003B1;2 GlyR channel is higher at negative potentials. Another peculiarity of NFA action on &#x003B1;2 GlyRs was the strong voltage dependence of inhibition (Figure <xref ref-type="fig" rid="F3">3C</xref>). Thus, at &#x02212;80 mV IC<sub>50</sub> of NFA was 166 &#x000B1; 28 &#x003BC;M, while at &#x0002B;80 mV it decreased nearly 20 times, to 9 &#x000B1; 2 &#x003BC;M (<italic>n</italic> &#x0003D; 8). Contrary to &#x003B1;1 GlyRs, the potency of NFA block did not increase further with elevation of glycine concentration (Figure <xref ref-type="fig" rid="F3">3D</xref>; <italic>p</italic> &#x0003E; 0.05). Currents induced by 100 &#x003BC;M of glycine were inhibited by NFA with IC<sub>50</sub> of 133 &#x000B1; 20 &#x003BC;M at &#x02212;80 mV and 9 &#x000B1; 2 &#x003BC;M at &#x0002B;80 mV (<italic>n</italic> &#x0003D; 7).</p>
<p>The strong voltage dependence of the block suggests that NFA is an open channel blocker interacting with residues located deeply in the pore.</p>
<p>This suggestion was confirmed by results of single channel recordings performed in outside-out patches from cells expressing &#x003B1;2 GlyRs in the presence of glycine or mixture of glycine with NFA (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">1</xref>). In control conditions, application of 5 &#x003BC;M glycine at V<sub>hold</sub> &#x02212;30 mV induced single channel openings (mean amplitude 2,8 pA) with rare short closings (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">1A</xref>). Addition of 30 &#x003BC;M NFA transferred rectangular single channel pulses into bursts with high frequency interburst flickering (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">1B</xref>). The effect became much more profound at elevation of the NFA concentration to 100 &#x003BC;M (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">1C</xref>). This phenomenology is similar to earlier described phenomenology of channel blockers, for instance, action of local anesthetics on single acetylcholine-receptor channels (Neher and Steinbach, <xref ref-type="bibr" rid="B51">1978</xref>) or flickering mode of NMDA receptors channel block by Mg<sup>&#x0002B;&#x0002B;</sup> (Nowak et al., <xref ref-type="bibr" rid="B54">1984</xref>) or amantadine (Blanpied et al., <xref ref-type="bibr" rid="B5">2005</xref>).</p>
</sec>
<sec>
<title>Action of niflumic acid on &#x003B1;3 GlyRs</title>
<p>Since NFA has shown distinct profiles of interaction with &#x003B1;1 and &#x003B1;2 GlyRs, we decided to explore its action on &#x003B1;3 GlyR with the aim to determine the critical amino acids for the blocker action. Notably, the TM2 helix in &#x003B1;3 GlyR is the same as in &#x003B1;2 GlyR. Both possess alanine in position 2&#x02032; (<bold>Figure 9A</bold>) implying that NFA may block &#x003B1;3 GlyR as strongly as &#x003B1;2 GlyR and stronger than &#x003B1;1 GlyR, which has glycine at position 2&#x02032;.</p>
<p>Indeed, during &#x0201C;long application&#x0201D; protocol, &#x003B1;3 GlyR-mediated currents induced by 100 &#x003BC;M of glycine (near EC<sub>50</sub> concentration for &#x003B1;3 GlyRs, Maleeva et al., <xref ref-type="bibr" rid="B41">2015</xref>) were blocked by NFA with the higher potency than currents mediated by &#x003B1;1 GlyRs (Figure <xref ref-type="fig" rid="F4">4A</xref>). 30 &#x003BC;M of NFA inhibited &#x003B1;3 GlyR-mediated currents by 32 &#x000B1; 4% at &#x02212;30 mV and by 62 &#x000B1; 5% at &#x0002B;30 mV, while 300 &#x003BC;M NFA at &#x02212;30 mV inhibited ionic currents by 86 &#x000B1; 5% and by 90 &#x000B1; 2% at &#x0002B;30 mV (<italic>n</italic> &#x0003D; 7). It is well documented that &#x003B1;3 GlyRs rapidly desensitize (Nikolic et al., <xref ref-type="bibr" rid="B53">1998</xref>) and this complicates accurate estimation of the NFA blocking potency. Thus, over all the cells percentage of inhibition was measured as the ratio of the current amplitudes at the maximal inhibition (<bold>I</bold><sub>1</sub>) and after washout of NFA, when the glycine-induced current reaches the quasi-stationary level (<bold>I</bold><sub>2</sub>, Figure <xref ref-type="fig" rid="F4">4A</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Action of NFA on &#x003B1;3 GlyRs. (A)</bold> Traces of the control glycine&#x02013;induced current (100 &#x003BC;M, left trace) and its inhibition by different concentrations of NFA (30 and 100 &#x003BC;M, middle and right traces). V<sub>hold</sub> is &#x0002B;30 mV (upper traces) and &#x02212;30 mV (bottom traces). I<sub>1</sub> and I<sub>2</sub> are amplitudes of currents used to calculate the degree of inhibition. <bold>(B)</bold> Representative current-voltage relationships recorded during application of glycine (100 &#x003BC;M) alone or in presence of different concentrations of NFA. <bold>(C)</bold> NFA IC<sub>50</sub> at different membrane potentials. Currents were estimated in the presence of 100 &#x003BC;M glycine. Data from 7 cells, represented as mean &#x000B1; SEM.</p></caption>
<graphic xlink:href="fnmol-10-00125-g0004.tif"/>
</fig>
<p>Interestingly, the current/voltage dependence recorded during application of 100 &#x003BC;M of glycine demonstrated the outward rectification, similar to that observed for &#x003B1;1 GlyRs. Like for both &#x003B1;1 and &#x003B1;2 GlyRs, the efficiency of &#x003B1;3 GlyRs block by NFA was higher at positive potentials (Figures <xref ref-type="fig" rid="F4">4B,C</xref>). At MP of &#x02212;80 mV and &#x0002B;80 mV, IC<sub>50</sub> of NFA was 86 &#x000B1; 14 and 16 &#x000B1; 6 &#x003BC;M, respectively (<italic>n</italic> &#x0003D; 7).</p>
<p>Thus, the sensitivity of &#x003B1;3 GlyRs to NFA is higher than that of &#x003B1;1 GlyRs and is rather close to that of &#x003B1;2 GlyRs.</p>
</sec>
<sec>
<title>Niflumic acid action on the &#x003B1;1 GlyR mutant G254A</title>
<p>Taking into account the voltage dependence and presumably pore-blocking mechanism of NFA action, we suggested that amino acids, which are crucial for the interaction of NFA with GlyRs, are located in the pore-lining helices. The TM2 helices are highly conserved between different &#x003B1; subunits of GlyRs and differ only at position 2&#x02032; where &#x003B1;1 subunit has glycine, while &#x003B1;2 and &#x003B1;3 subunits have alanine (<bold>Figure 9A</bold>). We suggested that this difference is the main determinant of the distinct profiles of inhibition of different GlyRs by NFA. To test this hypothesis, we performed a point mutation at position 254 of the &#x003B1;1 subunit exchanging glycine for alanine (Figure <xref ref-type="fig" rid="F5">5A</xref>). We expected to convert low NFA sensitivity of the &#x003B1;1 GlyR to high sensitivity, characteristic for &#x003B1;2 and &#x003B1;3 GlyRs.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>Action of NFA on G254A-&#x003B1;1 GlyR. (A)</bold> Amino acid sequences of the TM2 domain of &#x003B1;1 wild type and mutant subunits (mutated residue is highlighted by red) and recordings of inhibition of glycine-induced currents (30 &#x003BC;M) by different concentrations of NFA (30, 100, and 300 &#x003BC;M); V<sub>hold</sub> is &#x0002B;30 mV (upper traces) and &#x02212;30 mV (bottom traces). <bold>(B)</bold> Representative current-voltage relationships recorded during application of glycine (30 &#x003BC;M) alone or in the presence of different concentrations of NFA. <bold>(C)</bold> NFA IC<sub>50</sub> at different potentials, currents were induced by application of 30 &#x003BC;M (gray, <italic>n</italic> &#x0003D; 13) and 100 &#x003BC;M (green, <italic>n</italic> &#x0003D; 8) of glycine. <bold>(D)</bold> Comparison of NFA sensitivities of &#x003B1;1 GlyR wildtype (white, <italic>n</italic> &#x0003D; 8) and G254A-&#x003B1;1 GlyR (black, <italic>n</italic> &#x0003D; 13). Currents were induced by 30 &#x003BC;M glycine, <sup>&#x0002A;&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.001, unpaired <italic>t</italic>-test. Data represented as mean &#x000B1; SEM.</p></caption>
<graphic xlink:href="fnmol-10-00125-g0005.tif"/>
</fig>
<p>The dose/response relationships showed that the G254A-&#x003B1;1 GlyR mutant sensitivity to glycine is similar to that of the wild-type &#x003B1;1 GlyR: the EC<sub>50</sub> was 34 &#x000B1; 6 &#x003BC;M (<italic>n</italic> &#x0003D; 6, data not shown), which agrees with previous data (Shan et al., <xref ref-type="bibr" rid="B65">2001</xref>). At the &#x0201C;long application&#x0201D; protocol, NFA relatively weakly inhibited G254A-&#x003B1;1 GlyR mediated currents induced by 30 &#x003BC;M glycine, but its potency was higher than that in the wild-type &#x003B1;1 GlyRs (Figure <xref ref-type="fig" rid="F5">5A</xref>). At V<sub>hold</sub> of &#x02212;30 mV, 30, 100, and 300 &#x003BC;M of NFA inhibited G254A-&#x003B1;1 GlyR mediated currents by 22 &#x000B1; 4, 34 &#x000B1; 6, and 52 &#x000B1; 11%, respectively (<italic>n</italic> &#x0003D; 6), while at V<sub>hold</sub> of &#x0002B;30 mV, the same NFA concentrations inhibited currents by 23 &#x000B1; 7, 43 &#x000B1; 10, and 76 &#x000B1; 4%, respectively (<italic>n</italic> &#x0003D; 7).</p>
<p>Using the &#x0201C;ramp&#x0201D; protocol, we found the above effect to be more pronounced at higher potentials (Figure <xref ref-type="fig" rid="F5">5B</xref>). Notably, at &#x0002B;80 mV currents induced by 30 &#x003BC;M of glycine were inhibited by NFA with IC<sub>50</sub> of 64 &#x000B1; 10 &#x003BC;M (<italic>n</italic> &#x0003D; 13; Figure <xref ref-type="fig" rid="F5">5D</xref>), which was significantly lower (<italic>p</italic> &#x0003C; 0.001) than for the wild-type &#x003B1;1 GlyR (192 &#x000B1; 23 &#x003BC;M, <italic>n</italic> &#x0003D; 8). However, at negative potentials sensitivity of the G254A-&#x003B1;1 GlyR was close to that of wild type &#x003B1;1 GlyR and comprised 257 &#x000B1; 25 &#x003BC;M (<italic>n</italic> &#x0003D; 13). With the increase of agonist concentration, the strength of the block did not increase significantly and comprised 58 &#x000B1; 8 &#x003BC;M (<italic>n</italic> &#x0003D; 8) at MP &#x0003D; &#x0002B;80 mV.</p>
<p>Importantly, the NFA blocking potency for G254A-&#x003B1;1 GlyR was lower than that for &#x003B1;2 and &#x003B1;3 GlyRs. This suggests that amino acids beyond the TM2 helices affect the NFA action, likely by an allosteric mechanism.</p>
</sec>
<sec>
<title>Woodhull analysis of voltage dependence of the GlyR channel block by NFA</title>
<p>To estimate the fractional depth of the NFA binding sites in the pore with respect to the external membrane surface, we used classical Woodhull analysis developed to describe the hydrogen block of sodium channels (Woodhull, <xref ref-type="bibr" rid="B74">1973</xref>). We have plotted NFA IC<sub>50</sub> values against membrane potential for &#x003B1;1, &#x003B1;2, and G254A-&#x003B1;1 GlyRs at glycine concentrations of 30 and 100 &#x003BC;M (Figure <xref ref-type="fig" rid="F6">6A</xref>). The calculated values of &#x003B4; correspond to the percentage of the transmembrane electric field that is sensed by the bound NFA (Figure <xref ref-type="fig" rid="F6">6B</xref>). For the NFA block of &#x003B1;1 GlyR, mean &#x003B4; values at 30 and 100 &#x003BC;M of glycine were 0.16 &#x000B1; 0.03 (<italic>n</italic> &#x0003D; 7) and 0.26 &#x000B1; 0.02 (<italic>n</italic> &#x0003D; 10), respectively. The NFA binding site in &#x003B1;2 GlyR was found to be significantly deeper. With 30 and 100 &#x003BC;M of glycine, the sensed electric field (&#x003B4;) increased to 0.65 &#x000B1; 0.07 and 0.63 &#x000B1; 0.07, respectively (<italic>n</italic> &#x0003D; 7, <italic>p</italic> &#x0003C; 0.001). The NFA binding site in the G254A-&#x003B1;1 GlyR was situated between the sites in the &#x003B1;1 and &#x003B1;2 GlyRs, at the level of &#x0007E; 30% from the extracellular side at both examined agonist concentrations (Table <xref ref-type="table" rid="T1">1</xref>).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p><bold>Woodhull and cooperativity analysis of NFA interaction with &#x003B1;1, &#x003B1;2, and &#x003B1;1 G254A GlyRs. (A)</bold> Linear fit of the cumulative IC<sub>50</sub> values plotted against membrane potential for &#x003B1;1, &#x003B1;2 and G254A-&#x003B1;1 GlyRs. Currents were evoked by 30 &#x003BC;M of glycine (filled squares) or by 100 &#x003BC;M of glycine (empty circles). <bold>(B)</bold> Mean fractional depth of NFA binding in the pore (&#x003B4;) for &#x003B1;1 (black column), &#x003B1;2 (red) and G254A-&#x003B1;1 (blue) GlyRs. Currents were evoked by 30 (filled columns) and 100 &#x003BC;M (shaded) of glycine. Data from 6&#x02013;10 cells. <sup>&#x0002A;&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.001, unpaired <italic>t</italic>-test; n.s. &#x02013; nonsignificant. <bold>(C)</bold> Cumulative n<sub>H</sub> values of NFA interaction with &#x003B1;1 (black squares, <italic>n</italic> &#x0003D; 6), &#x003B1;2 (red circles, <italic>n</italic> &#x0003D; 6) and G254A-&#x003B1;1 (blue triangles, <italic>n</italic> &#x0003D; 5) GlyRs plotted against membrane potentials. Currents were evoked by 30 &#x003BC;M of glycine. Data represented as mean &#x000B1; SEM.</p></caption>
<graphic xlink:href="fnmol-10-00125-g0006.tif"/>
</fig>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Fractional electrical distance (&#x003B4;) from the extracellular side of the membrane at which NFA blocks the pore in &#x003B1;1, &#x003B1;2 and G254A-&#x003B1;1 GlyRs</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Glycine concentration</bold></th>
<th valign="top" align="center"><bold>&#x003B1;1 GlyR</bold></th>
<th valign="top" align="center"><bold>&#x003B1;2 GlyR</bold></th>
<th valign="top" align="center"><bold>G254A-&#x003B1;1 GlyR</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">30 &#x003BC;M</td>
<td valign="top" align="center">0.16 &#x000B1; 0.03 (<italic>n</italic> &#x0003D; 7)</td>
<td valign="top" align="center">0.65 &#x000B1; 0.07 (<italic>n</italic> &#x0003D; 7)</td>
<td valign="top" align="center">0.37 &#x000B1; 0.04 (<italic>n</italic> &#x0003D; 9)</td>
</tr>
<tr>
<td valign="top" align="left">100 &#x003BC;M</td>
<td valign="top" align="center">0.26 &#x000B1; 0.02 (<italic>n</italic> &#x0003D; 10)</td>
<td valign="top" align="center">0.63 &#x000B1; 0.07 (<italic>n</italic> &#x0003D; 7)</td>
<td valign="top" align="center">0.30 &#x000B1; 0.04 (<italic>n</italic> &#x0003D; 7)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>The data are represented as mean &#x000B1; SEM</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Hill coefficient of NFA/GlyR interaction</title>
<p>To estimate cooperativity of NFA inhibition of GlyRs, we determined the Hill coefficient (n<sub>H</sub>) for &#x003B1;1, &#x003B1;2, and G254A-&#x003B1;1 GlyRs. The amplitude of glycine-evoked currents at different potentials was plotted against the NFA concentration and fitted with the Hill equation. At positive membrane potentials, n<sub>H</sub> decreased with the membrane depolarization for the three GlyRs (Table <xref ref-type="table" rid="T2">2</xref> and Figure <xref ref-type="fig" rid="F6">6C</xref>). For &#x003B1;1 and &#x003B1;2 GlyRs n<sub>H</sub> was significantly different at all the tested membrane potentials (&#x02212;80 mV, &#x02212;70 mV <italic>p</italic> &#x0003C; 0.001; &#x02212;50 &#x02013; &#x0002B;50 mV <italic>p</italic> &#x0003C; 0.01; 70, 80 mV <italic>p</italic> &#x0003C; 0.05), and for the G254A-&#x003B1;1 GlyR n<sub>H</sub> values were between those for &#x003B1;1 and &#x003B1;2 GlyRs. Concentration dependencies of NFA action on different GlyR subunits are presented in the Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">2</xref>.</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p><bold>Hill coefficient (n<sub>H</sub>) of NFA interaction with &#x003B1;1, &#x003B1;2, and G254A-&#x003B1;1 GlyRs at different membrane potentials</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>Membrane potential (mV)</bold></th>
<th valign="top" align="center"><bold>&#x003B1;1 GlyR (<italic>n</italic> &#x0003D; 6)</bold></th>
<th valign="top" align="center"><bold>&#x003B1;2 GlyR (<italic>n</italic> &#x0003D; 6)</bold></th>
<th valign="top" align="center"><bold>G254A-&#x003B1;1 GlyR (<italic>n</italic> &#x0003D; 5)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">&#x02212;80</td>
<td valign="top" align="center">1.56 &#x000B1; 0.07</td>
<td valign="top" align="center">1.05 &#x000B1; 0.06</td>
<td valign="top" align="center">1.46 &#x000B1; 0.16</td>
</tr>
<tr>
<td valign="top" align="left">&#x02212;70</td>
<td valign="top" align="center">1.65 &#x000B1; 0.08</td>
<td valign="top" align="center">1.04 &#x000B1; 0.08</td>
<td valign="top" align="center">1.34 &#x000B1; 0.1</td>
</tr>
<tr>
<td valign="top" align="left">&#x02212;50</td>
<td valign="top" align="center">1.7 &#x000B1; 0.08</td>
<td valign="top" align="center">1.14 &#x000B1; 0.12</td>
<td valign="top" align="center">1.37 &#x000B1; 0.18</td>
</tr>
<tr>
<td valign="top" align="left">30</td>
<td valign="top" align="center">1.87 &#x000B1; 0.02</td>
<td valign="top" align="center">1.1 &#x000B1; 0.14</td>
<td valign="top" align="center">1.3 &#x000B1; 0.08</td>
</tr>
<tr>
<td valign="top" align="left">50</td>
<td valign="top" align="center">1.55 &#x000B1; 0.08</td>
<td valign="top" align="center">1 &#x000B1; 0.14</td>
<td valign="top" align="center">1.36 &#x000B1; 0.11</td>
</tr>
<tr>
<td valign="top" align="left">70</td>
<td valign="top" align="center">1.5 &#x000B1; 0.11</td>
<td valign="top" align="center">1 &#x000B1; 0.13</td>
<td valign="top" align="center">1.26 &#x000B1; 0.1</td>
</tr>
<tr>
<td valign="top" align="left">80</td>
<td valign="top" align="center">1.28 &#x000B1; 0.07</td>
<td valign="top" align="center">0.97 &#x000B1; 0.09</td>
<td valign="top" align="center">1.22 &#x000B1; 0.09</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Data are represented as mean &#x000B1; SEM</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>These data suggest that the cooperativity of NFA block strongly depends on the GlyR subtype.</p>
</sec>
<sec>
<title>Action of niflumic acid on &#x003B1;1&#x003B2; and &#x003B1;2&#x003B2; GlyRs</title>
<p>In the adult CNS of vertebrates, the predominant GlyR subtype is heteromeric &#x003B1;1&#x003B2; (Lynch, <xref ref-type="bibr" rid="B39">2004</xref>). Several inhibitors, e.g., picrotoxin (Pribilla et al., <xref ref-type="bibr" rid="B55">1992</xref>; Wang et al., <xref ref-type="bibr" rid="B72">2006</xref>) and ginkgolides (Kondratskaya et al., <xref ref-type="bibr" rid="B32">2005</xref>) have different affinity in heteromeric and homomeric GlyRs. To estimate the NFA sensitivity to heteromeric GlyRs we studied its interaction with &#x003B1;1&#x003B2; and &#x003B1;2&#x003B2; GlyRs. The concentration of the agonist was chosen according to the previous studies, demonstrating that 30 &#x003BC;M of glycine is below EC<sub>50</sub> for &#x003B1;1&#x003B2; and &#x003B1;2&#x003B2; glycine receptors (Rundstrom et al., <xref ref-type="bibr" rid="B60">1994</xref>; Miller et al., <xref ref-type="bibr" rid="B46">2005</xref>).</p>
<p>To prove formation of functional heteromeric GlyRs, we implemented a widely used picrotoxin (PTX) test: PTX blocks &#x003B1;X&#x003B2; GlyRs much weaker than homomeric &#x003B1;X GlyRs (Pribilla et al., <xref ref-type="bibr" rid="B55">1992</xref>; Shan et al., <xref ref-type="bibr" rid="B65">2001</xref>). In our preparations, under application of 20 &#x003BC;M of PTX amplitudes of &#x003B1;1 and &#x003B1;2 GlyR -mediated currents were, respectively, 27 &#x000B1; 3% (<italic>n</italic> &#x0003D; 12) and 3 &#x000B1; 1% (<italic>n</italic> &#x0003D; 9) of the control. Heteromeric GlyRs were inhibited much weaker: the current in &#x003B1;1&#x003B2; GlyR was 75 &#x000B1; 2% (<italic>n</italic> &#x0003D; 15) and in &#x003B1;2&#x003B2; GlyR it was 41 &#x000B1; 4% (<italic>n</italic> &#x0003D; 7) from the control (Figures <xref ref-type="fig" rid="F7">7A&#x02013;C</xref>).</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p><bold>Inhibition of homomeric and heteromeric receptors by picrotoxin. (A)</bold> The action of PTX (20 &#x003BC;M) on currents mediated by &#x003B1;1&#x003B2; (upper trace) and &#x003B1;1 GlyRs (bottom trace). The currents were evoked by 30 &#x003BC;M of glycine; V<sub>hold</sub> &#x0003D; &#x02212;30 mV. <bold>(B)</bold> The action of PTX (20 &#x003BC;M) on currents mediated by &#x003B1;2&#x003B2; (upper trace) and &#x003B1;2GlyRs (bottom trace). The currents were evoked by 30 &#x003BC;M of glycine; V<sub>hold</sub> &#x0003D; &#x02212;30 mV. For clarity, dotted lines show the current levels in the absence of the agonist. <bold>(C)</bold> Percentage of the remained current from control under application of PTX (20 &#x003BC;M) for &#x003B1;1 (<italic>n</italic> &#x0003D; 12), &#x003B1;1&#x003B2; (<italic>n</italic> &#x0003D; 15), &#x003B1;2 (<italic>n</italic> &#x0003D; 9), and &#x003B1;2&#x003B2; (<italic>n</italic> &#x0003D; 7) GlyRs (homomeric receptors&#x02014;blue, heteromeric&#x02014;green). Data represented as mean &#x000B1; SEM, <sup>&#x0002A;&#x0002A;&#x0002A;</sup><italic>p</italic> &#x0003C; 0.001, unpaired <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fnmol-10-00125-g0007.tif"/>
</fig>
<p>Estimation of NFA IC<sub>50</sub> at different membrane potentials has shown that incorporation of the &#x003B2; subunit does not change significantly (<italic>p</italic> &#x0003E; 0.05) the sensitivity of &#x003B1;1 GlyR to NFA: at &#x0002B;80 mV IC<sub>50</sub> of NFA was 150 &#x000B1; 14 &#x003BC;M (<italic>n</italic> &#x0003D; 5) (Figure <xref ref-type="fig" rid="F8">8A</xref>). Analysis of I/V curves also revealed a similarity to &#x003B1;1 GlyRs: currents mediated by &#x003B1;1&#x003B2; GlyRs (30 &#x003BC;M of glycine) were outwardly rectifying (data not shown).</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p><bold>Action of NFA on heteromeric &#x003B1;1&#x003B2; and &#x003B1;2&#x003B2; GlyRs. (A)</bold> NFA IC<sub>50</sub> values for &#x003B1;1 (blue, <italic>n</italic> &#x0003D; 10) and &#x003B1;1&#x003B2; (gray, <italic>n</italic> &#x0003D; 5) GlyRs at different potentials. Currents were induced by application of 30 &#x003BC;M glycine. <bold>(B)</bold> Normalized representation of current-voltage relations from two cells expressing &#x003B1;2 (blue) and &#x003B1;2&#x003B2; (orange) GlyRs at application 30 &#x003BC;M glycine. <bold>(C)</bold> Representative I/V curves from one cell recorded for &#x003B1;2&#x003B2; GlyR during application of 30 &#x003BC;M of glycine alone or in the presence of different concentrations of NFA. <bold>(D)</bold> Comparison of NFA IC<sub>50</sub> for &#x003B1;2 (blue, <italic>n</italic> &#x0003D; 7) and &#x003B1;2&#x003B2; (gray, <italic>n</italic> &#x0003D; 5) GlyRs at different potentials. Currents were induced by application of 30 &#x003BC;M of glycine. Data represented as mean &#x000B1; SEM, <sup>&#x0002A;</sup><italic>p</italic> &#x0003C; 0.05, unpaired <italic>t</italic>-test.</p></caption>
<graphic xlink:href="fnmol-10-00125-g0008.tif"/>
</fig>
<p>Surprisingly, &#x003B1;2&#x003B2; GlyRs demonstrated the outwardly rectifying currents, contrary to inwardly rectifying &#x003B1;2 GlyRs (Figures <xref ref-type="fig" rid="F8">8B,C</xref>). In comparison to &#x003B1;2 GlyRs NFA stronger inhibited heteromeric &#x003B1;2&#x003B2; receptors at negative potentials being less effective at positive ones. This resulted in slightly weaker voltage dependence of the block vs. homomeric GlyRs: at &#x02212;80 and &#x0002B;80 mV, IC<sub>50</sub> was 107 &#x000B1; 37 and 20 &#x000B1; 8 &#x003BC;M, respectively (<italic>n</italic> &#x0003D; 5, Figure <xref ref-type="fig" rid="F8">8D</xref>). In general, the &#x003B2; subunit does not have a strong impact on the interaction of NFA with GlyRs.</p>
</sec>
<sec>
<title>Computational search for possible NFA binding sites in the pore of GlyRs</title>
<p>A systematic search for possible binding sites of NFA in different regions of the large GlyR proteins was beyond goals of this study. Here we focused on the pore region where NFA is likely to bind. Several arguments support this proposition. First, the voltage-dependence of the NFA action (Figures <xref ref-type="fig" rid="F2">2</xref>&#x02013;<xref ref-type="fig" rid="F6">6</xref>) strongly suggests that the compound binds within the membrane. Second, the anionic NFA molecules would enjoy favorable electrostatic interactions within the anion-selective pore. Third, results of single channels experiments demonstrated dramatical increase of the open state fluctuations caused by NFA application. Fourth, upon the channel activation, the &#x003B1;2 GlyR appears to open for a longer time than &#x003B1;1 GlyR (Takahashi et al., <xref ref-type="bibr" rid="B70">1992</xref>; Morales et al., <xref ref-type="bibr" rid="B48">1994</xref>). The longer openings would give NFA molecules more chances to reach their binding site(s) within the pore. This may explain why &#x003B1;2 GlyR is more sensitive to the NFA block than &#x003B1;1 GlyR.</p>
<p>Figure <xref ref-type="fig" rid="F9">9B</xref> shows computed energy (kcal/mol) of NFA interaction with &#x003B1;1 and &#x003B1;2 GlyR models and Figure <xref ref-type="fig" rid="F10">10A</xref> shows superposition of 74 snapshots with NFA at different levels of the &#x003B1;2 GlyR pore. The &#x003B1;1 and &#x003B1;2 GlyR models differ only at level 2&#x02032; where they have, respectively, the rings of Gly254 and Ala254 residues, but the computed energy values are rather different at each level (Figure <xref ref-type="fig" rid="F9">9B</xref>). The cause is the NFA molecule size (&#x0007E;13 &#x000C5; between most remote atoms, see Figure <xref ref-type="fig" rid="F1">1B</xref>), which is bigger than, e.g., the distance of 5.8 &#x000C5; between C<sup>&#x003B2;</sup> atoms of the same TM2 helix at levels 2&#x02032; and 6&#x02032;. Since the preferable orientation of NFA in the pore is unknown, the NFA molecule was allowed to rotate during MC-minimizations at each step. As a result, once the energetically favorable orientation was found at some level, the probability to find the energetically better orientation at the same level become small. A bottom line from a large number of independent runs with different seed random numbers might yield smoother trajectories, but such computations, which would require large computational resources, were beyond goals of our study.</p>
<fig id="F9" position="float">
<label>Figure 9</label>
<caption><p><bold>Monte Carlo energy minimized profiles of NFA pulled through the pore models of &#x003B1;1 and &#x003B1;2 GlyRs. (A)</bold> A schematic view of the rings of the pore-facing residues at different levels of the pore. Relative dimensions of the rings and distances between the planes do not exactly match the computational models. Amino acid sequences of the pore-lining TM2 helices in &#x003B1;1, &#x003B1;2/&#x003B1;3, and &#x003B2; subunits left to the scheme should be read from the bottom to the top. The numbering of amino acids is used as for human &#x003B1;1 GlyR starting with the N-terminal, i.e., without the signal peptide sequences (Grenningloh et al., <xref ref-type="bibr" rid="B22">1990</xref>), as was used previously (David-Watine et al., <xref ref-type="bibr" rid="B13">1999</xref>; Imboden et al., <xref ref-type="bibr" rid="B27">2001</xref>; Breitinger et al., <xref ref-type="bibr" rid="B8">2004</xref>). Note hydrophilic rings Thr<sup>265(13&#x02032;)</sup> and Thr<sup>258(6&#x02032;)</sup> above and below the hydrophobic ring Leu<sup>261(9&#x02032;)</sup>. Rings Gly<sup>254(2&#x02032;)</sup> in &#x003B1;1 GlyRs and Gly<sup>269(17&#x02032;)</sup> are indicated as hydrophilic ones because their hydrophilic backbone atoms are exposed to the pore. <bold>(B)</bold> Interaction energy of NFA with the &#x003B1;1 and &#x003B1;2 GlyR models plotted against position of the NFA central nitrogen atom (N1, see Figure <xref ref-type="fig" rid="F1">1B</xref>). At each level of the pore, atom N1 was constrained to a plane, which is normal to the pore axis. During the MCM search for energetically preferable orientation of NFA at the given level, atom N1 was free to move within this plane and NFA molecule was free to rotate around N1. The arrows indicate positions of the N1 atom at the levels of pore-facing residues. Note that at some orientations the NFA molecule may extend along the pore up to 13 &#x000C5; (Figure <xref ref-type="fig" rid="F1">1B</xref>) and thus interact with the pore-facing residues below and above the level where the N1 atom was constrained. For example, at level 2&#x02032;, the &#x003B1;2 GlyR channel contains five pore-facing alanine residues, which are more attractive to the NFA molecule than five Gly2&#x02032; residues in the &#x003B1;1 GlyR channel. However, even when the N1 atom is constrained at level 6&#x02032;, one part of the NFA molecule could interact with residues at level 2&#x02032; and another part with residues at level 9&#x02032; (Figure <xref ref-type="fig" rid="F10">10D</xref>).</p></caption>
<graphic xlink:href="fnmol-10-00125-g0009.tif"/>
</fig>
<fig id="F10" position="float">
<label>Figure 10</label>
<caption><p><bold>Models of NFA binding in the GlyRs. (A)</bold> Superposition of snapshots with NFA at different levels of the &#x003B1;2 GlyR model. Front subunit is removed for clarity. At each level, the energy is MC-minimizes as described in Materials and Methods. <bold>(B)</bold> Cytoplasmic view at &#x003B1;2 GlyR with the NFA molecule electrostatically attracted to Arg252. Due to this attraction both &#x003B1;1GlyR-NFA and &#x003B1;2 GlyR-NFA trajectories have deep minima at level &#x02212;2&#x02032;. <bold>(C)</bold> Side view of the &#x003B1;1 GlyR model with NFA at level 9&#x02032;, which corresponds to the energy maxima in Figure <xref ref-type="fig" rid="F9">9</xref>. At this level NFA squeezes through the pore constriction formed by the Leu<sup>261(9&#x02032;)</sup> residues, but due to deep penetration of the NFA carboxylic group between two M2 helices, it may accept up to four H-bonds from Thr<sup>258(6&#x02032;)</sup>, Thr<sup>262</sup>, Thr<sup>264</sup> and Thr<sup>265(13&#x02032;)</sup>. <bold>(D&#x02013;F)</bold> Intracellular, side, and enlarged side views of the &#x003B1;2 GlyR model with atom N1 of NFA bound level 6&#x02032;, where a minimum is seen at the energy profile (Figure <xref ref-type="fig" rid="F9">9B</xref>). The front subunit is removed for clarity at <bold>(E,F)</bold>. NFA accepts an H-bond from Thr<sup>258(6&#x02032;)</sup> and forms hydrophobic contacts with the rings of Ala<sup>254(2&#x02032;)</sup> and Leu<sup>261(9&#x02032;)</sup> residues by the trifluoromethyl-aryl and pyridine groups, respectively. <bold>(G&#x02013;I)</bold> Extracellular, side, and enlarged side views of the &#x003B1;1 GlyR model two NFA molecules bound above the Leu<sup>261(9&#x02032;)</sup> ring. The front subunit is removed for clarity at <bold>(H,I)</bold>. Both NFA molecules accept H-bonds from Thr<sup>265(13&#x02032;)</sup>, and form hydrophobic contacts with each other and Leu<sup>261(9&#x02032;)</sup> residues.</p></caption>
<graphic xlink:href="fnmol-10-00125-g0010.tif"/>
</fig>
<p>The NFA interaction energy with the &#x003B1;1 and &#x003B1;2 GlyR models differs not only around level 2&#x02032;, but also at the levels where the pore-facing residues are identical. At most of the levels, the energy difference between the two models does not exceed 2 kcal/mol, but it reaches 5 kcal/mol at level 6&#x02032; (Thr258). Despite the differences, the two trajectories have several common features as described below. First, there are rather deep minima at the cytoplasmic side of the pore, which are due to electrostatic interactions between NFA and Arg252 (Figure <xref ref-type="fig" rid="F10">10B</xref>). Second, there are energy minima at level 6&#x02032;, which are due to H-bonds between NFA and Thr258 residues and hydrophobic interactions of NFA with the intracellularly-oriented side of the Leu261 ring. Third, there are energy minima at level 13&#x02032;, which are due to H-bonds between NFA and Thr265 and favorable hydrophobic interactions of NFA with the extracellularly-oriented side of the Leu261 ring. Fourth, there are energy maxima at level 9&#x02032;, which are due to certain repulsion between NFA and Leu261 residues that form the open pore constriction. However, even at this level the NFA-channel energy remains favorable (around &#x02212;10 kcal/mol), partially because the ligand carboxylic group can accept up to four H-bonds from Thr258, Thr264, and Thr265 (Figure <xref ref-type="fig" rid="F10">10C</xref>). Fifth, relatively large energies at the extracellular part of the pore (levels 17&#x02032; to 20&#x02032;) are due to two reasons. (i) The pore at these levels is too wide and NFA cannot simultaneously interact with three helices as it does at lower levels. (ii) Levels 13&#x02032; and 17&#x02032; are both hydrophilic (Figure <xref ref-type="fig" rid="F9">9A</xref>) and predominantly hydrophobic NFA cannot form multiple favorable contacts with the pore-facing residues.</p>
<p>Based on these results we suggest that there are more than one site along the pore where NFA can bind and block the ion permeation. The most likely locations of the NFA binding sites are at the opposite sides of the Leu261 ring, which forms the open pore constriction. And the most likely mechanism of the current block is the combination of the hydrophobic and steric block: NFA exposes its hydrophobic groups to the pore lumen, binds above and/or below the Leu261 ring and thus precludes permeation of the hydrated chloride ion. This block may be enforced by the electrostatic repulsion of the negatively charged carboxylate group of NFA and negatively charged chloride ions.</p>
<p>Our data on the Hill coefficient and the fractional electrical distance of the NFA binding site suggest two peculiarities of NFA action on GlyRs. Firstly, two NFA molecules preferably block permeation through the &#x003B1;1 GlyR channel, whereas the &#x003B1;2 GlyR channel is blocked by a single NFA molecule. Secondly, the NFA binding site in the &#x003B1;2 GlyR is located deeper than in the &#x003B1;1 GlyR. These experimental data provide important constraints to further elaborate models of NFA-bound &#x003B1;1 and &#x003B1;2 GlyRs.</p>
<p>The &#x003B1;2 GlyR block by a single NFA molecule bound deeply inside the pore can be illustrated by the binding mode found without constraints (Figures <xref ref-type="fig" rid="F10">10D&#x02013;F</xref>). In this mode, NFA binds between hydrophobic rings Ala254 and Leu261 and accepts an H-bond from Thr258. This and similar binding modes collected in the MC-minimizations correspond to the energy minima at the left part of the energy profile (Figure <xref ref-type="fig" rid="F9">9B</xref>).</p>
<p>The energy profile of NFA in the &#x003B1;1 GlyR shows that NFA-channel interactions at levels &#x02212;2&#x02032; to 6&#x02032; are energetically less preferable than in the &#x003B1;2 GlyR. A reason is the ring of Gly254 residues in &#x003B1;1 GlyR, which does not form as favorable van der Walls and hydrophobic contacts with NFA as the ring of Ala254 residues in &#x003B1;2 GlyR does. In particular, water molecules that hydrate the pore-exposed hydrophilic backbone atoms of Gly254 residues would destabilize binding of the hydrophobic NFA.</p>
<p>A complex &#x003B1;1 GlyR with a single NFA bound above the ring of Leu261 residues, at level 13&#x02032; (Thr265) corresponds to the wide energy minima (Figure <xref ref-type="fig" rid="F9">9B</xref>). We docked the second NFA molecules to this complex and MC-minimizing the energy. The pore easily accommodated two NFA molecules at this level and calculations predicted several possible low-energy binding modes of the two ligands. One of these is shown at Figures <xref ref-type="fig" rid="F10">10G&#x02013;I</xref>, where two NFA molecules form favorable hydrophobic contacts with each other and the extracellularly-oriented side of the Leu261 ring, thus blocking the ion permeation, whereas their carboxylate groups accept H-bonds from the Thr265 residues.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>NFA is an anti-inflammatory drug clinically used for the relief of chronic and acute pain (Cremonesi and Cavalieri, <xref ref-type="bibr" rid="B12">2015</xref>). In comparison with other nonsteroidal anti-inflammatory drugs or nonopioid analgesics, it is not associated with side effects, particularly, reactions in children (Sturkenboom et al., <xref ref-type="bibr" rid="B69">2005</xref>). NFA is also widely used for inhibition of some types of Cl<sup>&#x02212;</sup>-selective channels, blocking primary voltage-gated CLC-1 channels (Sturkenboom et al., <xref ref-type="bibr" rid="B69">2005</xref>) and Ca<sup>2&#x0002B;</sup>-activated Cl<sup>&#x02212;</sup> channels (CaCCs) (White and Aylwin, <xref ref-type="bibr" rid="B73">1990</xref>; Yang et al., <xref ref-type="bibr" rid="B75">2008</xref>; Huanosta-Gutierrez et al., <xref ref-type="bibr" rid="B26">2014</xref>).</p>
<p>It has been shown that a distinct branch of the CLC protein family, ClC-K kidney Cl<sup>&#x02212;</sup> channels, which are important for renal and inner ear trans-epithelial Cl<sup>&#x02212;</sup> transport (Zifarelli and Pusch, <xref ref-type="bibr" rid="B79">2007</xref>), are modulated by NFA in a biphasic way: it activates ClC-K at low concentrations, but blocks the channels at high concentrations, above &#x0007E;1 mM (Zifarelli et al., <xref ref-type="bibr" rid="B78">2010</xref>). Guided by the crystal structure of a bacterial CLC homolog and site-directed mutations of ClC-K, authors suggested three amino acids as candidates for the potentiation effect of NFA. A subunit-specific NFA action has been demonstrated on the ligand-gated Cl<sup>&#x02212;</sup>-permeable GABA<sub><italic>A</italic></sub> receptors. Those, formed by &#x003B1;1/&#x003B2;2/&#x003B3;2 subunits, the main receptor combination in the brain, were potentiated by application of NFA, while &#x003B1;6/&#x003B2;2/&#x003B3;2 and &#x003B1;1/&#x003B2;2, &#x003B1;6/&#x003B2;2 receptors were inhibited by NFA (Sinkkonen et al., <xref ref-type="bibr" rid="B67">2003</xref>). These observations suggest that NFA regulates the function of different Cl-selective channels via different pathways. However, molecular mechanisms of its action on Cys-loop receptors are elusive.</p>
<p>Here we used electrophysiological, mutational and molecular modeling analyses to investigate the effects of NFA on Cl<sup>&#x02212;</sup>-selective GlyR channels of known subunit composition. We have demonstrated that NFA inhibits currents mediated by homomeric &#x003B1;1, &#x003B1;2, and &#x003B1;3 GlyRs with different efficacy: &#x003B1;1 receptors demonstrated the lowest affinity to NFA, while for &#x003B1;2 and &#x003B1;3 GlyRs the NFA affinity was more than ten times higher (Figures <xref ref-type="fig" rid="F2">2</xref>, <xref ref-type="fig" rid="F3">3</xref>). Inhibition of all three types of GlyRs by NFA was voltage dependent with higher affinity at positive potentials. This effect was especially pronounced for &#x003B1;2 GlyRs. The voltage dependence of NFA action allowed us to suggest that the site(s) of NFA interaction with GlyR are located in the channel pore. Moreover, the Woodhull analysis suggested that the NFA binding site in &#x003B1;1 GlyR is closer to the external part of the membrane, while for &#x003B1;2 GlyR it is significantly deeper in the pore.</p>
<p>The NFA ability to block &#x003B1;1 GlyRs at positive potentials significantly increased with the concentration of the glycine. In contrast, this effect in &#x003B1;2 GlyRs was not observed. We suggest that this difference is due to the different kinetics of channels&#x00027; gating. Analysis of single-channel properties demonstrated that the mean open time of &#x003B1;2 GlyR channels exceeds that of &#x003B1;1 channels by almost 100-fold (Takahashi et al., <xref ref-type="bibr" rid="B70">1992</xref>). Presumably, the different NFA potency in blocking the &#x003B1;1 GlyR currents induced by 30 and 100 &#x003BC;M of glycine is due to the different mean open times of the channel. Augmentation of the agonist concentration did not have an impact on the &#x003B1;2 GlyR block by NFA because in this GlyR subtype the mean open time even at low concentration of glycine was long enough for development of the maximum NFA effect.</p>
<p>The ion-conducting pore of GlyRs is lined by TM2 helices of five subunits. The TM2 segments of different alpha subunits differ only at the 2&#x02032; position: &#x003B1;1 receptors contain Gly, while &#x003B1;2 and 3 subunits have Ala (Figure <xref ref-type="fig" rid="F9">9A</xref>). The pore-blocking mechanism of NFA action suggests that the revealed difference in NFA sensitivity of different GlyRs is due, primarily, to different amino acids in the 2&#x02032; position.</p>
<p>In order to verify this, we have performed a point mutation in &#x003B1;1 subunit exchanging Gly254 for Ala. The G254A-&#x003B1;1 mutant was more sensitive to NFA than wild-type &#x003B1;1 GlyR and the NFA block in the mutant increased at positive potentials. However, this mutation did not convert completely the profile of &#x003B1;1 GlyR interaction with NFA to the one of &#x003B1;2 GlyR, suggesting that amino acids beyond the TM2 segments also influence the NFA action.</p>
<p>In our study, we have confirmed the importance of 2&#x02032; residue of TM2 segments in determining the action of pore-blocking molecules on GlyR. Several studies provided evidence of the implication of this amino acid in the interaction of GlyR with ion channel blockers (Pribilla et al., <xref ref-type="bibr" rid="B55">1992</xref>; Rundstrom et al., <xref ref-type="bibr" rid="B60">1994</xref>; Shan et al., <xref ref-type="bibr" rid="B65">2001</xref>). For instance, cyanotryphenilborate (CTB) blocks &#x003B1;1 GlyRs more potently than &#x003B1;2 GlyRs, while mutation G254A in the &#x003B1;1 subunit makes the channel less sensitive to CTB (Rundstrom et al., <xref ref-type="bibr" rid="B60">1994</xref>).</p>
<p>A prominent difference in the voltage dependence of &#x003B1;1 and &#x003B1;2 GlyRs block by NFA motivated us to implement the Woodhull analysis to determine the fractional electrical distance (&#x003B4;) from the external side of the membrane at which NFA molecules bind to the &#x003B1;1, &#x003B1;2, and G254A-&#x003B1;1GlyRs. This analysis revealed that the &#x003B4; value was largely different in different GlyR subtypes. Thus, the currents evoked by 100 &#x003BC;M of glycine were inhibited by NFA with higher potency likely due to the increase of the accessibility of deeper parts of the pore. A similar explanation is possible for the high NFA potency in &#x003B1;2 GlyRs. NFA molecules could penetrate to the pore by more than 60% of its length. The G254A-&#x003B1;1GlyR mutant, which had a higher NFA sensitivity than the &#x003B1;1 wild-type, also has a more extracellularly located NFA binding site.</p>
<p>Previous studies that considered voltage dependence of currents mediated by GlyRs formed a discrepant picture. Glycine-evoked currents demonstrated both an outwardly rectifying (Bormann et al., <xref ref-type="bibr" rid="B6">1987</xref>; Schmieden et al., <xref ref-type="bibr" rid="B64">1989</xref>; Morales et al., <xref ref-type="bibr" rid="B48">1994</xref>; Downie et al., <xref ref-type="bibr" rid="B14">1996</xref>; Fucile et al., <xref ref-type="bibr" rid="B18">1999</xref>) and linear behaviors (Bormann et al., <xref ref-type="bibr" rid="B7">1993</xref>; Wang et al., <xref ref-type="bibr" rid="B72">2006</xref>) upon gradually changing V<sub>hold</sub>. This difference may be resulted from the use of different agonist concentrations and protocols of voltage change. Earlier study presented a clear explanation of these changes in I/V relations (Akaike et al., <xref ref-type="bibr" rid="B1">1986</xref>).</p>
<p>A systematic study of I/V relations for different subunits of GlyRs was undertaken recently, but for desensitized channels, activated by high concentration of glycine (Raltschev et al., <xref ref-type="bibr" rid="B58">2016</xref>). It was shown that currents mediated by &#x003B1;2 and &#x003B1;3 GlyRs in desensitized state are inwardly rectifying, while &#x003B1;1 GlyRs currents are linear. These results are partially overlapping with ours, but they cannot be fairly compared as Raltschev et al. (<xref ref-type="bibr" rid="B58">2016</xref>) studied desensitized receptors.</p>
<p>The Hill equation analysis demonstrated the different degree of cooperativity of NFA inhibitory action. It was higher for &#x003B1;1 GlyRs with n<sub>H</sub>close to 1.5 suggesting at least two molecules of NFA are necessary to block the pore, while for &#x003B1;2 GlyR n<sub>H</sub> was close to 1. While there is no direct relation between Hill coefficients and stoichiometry of interaction, our observation that nH for &#x003B1;1 receptors is higher than for &#x003B1;2 receptors is in agreement with the proposed binding of two NFA molecules in the pore of alpha GlyR channels and supported by the model analysis.</p>
<p>Heteromeric &#x003B1;1&#x003B2; and &#x003B1;2&#x003B2; receptors were also inhibited by NFA. Incorporation of &#x003B2; subunit did not change significantly sensitivity of &#x003B1;1&#x003B2; GlyR to NFA, while at positive potentials NFA inhibited the &#x003B1;2&#x003B2; GlyR less potently than &#x003B1;2 receptors. The amino acid sequence of &#x003B2; subunit is very different from &#x003B1; subunits (Figure <xref ref-type="fig" rid="F9">9A</xref>). It was shown that Phe258 plays important role in determining the &#x003B1;1&#x003B2; sensitivity to PTX, and its substitution for threonine significantly increases the affinity of heteromeric receptors to PTX (Shan et al., <xref ref-type="bibr" rid="B65">2001</xref>).</p>
<p>Our molecular modeling provided the possible structural rationale for the experimental data. The likely reason for the different strength, depth and stoichiometry of NFA binding in &#x003B1;1 and &#x003B1;2 GlyRs is favorable interactions of the hydrophobic ligand with the hydrophobic 2&#x02032; alanine ring in &#x003B1;2 GlyR and unfavorable interactions with the hydrated 2&#x02032; glycine ring in &#x003B1;1 GlyR. Being unable to bind at the 2&#x02032; glycine ring in &#x003B1;1 GlyR, NFA binds at the upper, wider levels of the pore that can accommodate two ligands. In a simplified way, NFA can be described as a molecule with two hydrophobic ends and a hydrophilic middle part (Figure <xref ref-type="fig" rid="F1">1</xref>). Such a molecule would favorably interact with the channel that has a hydrophilic ring with hydrophobic rings below and above it. The rings of Ala254, Thr258, and Leu261 residues in &#x003B1;2 GlyR do form such a pattern. &#x003B1;1 GlyR lacks such a pattern, and in the absence of the second hydrophobic ring, two NFA molecules enjoy hydrophobic contacts with each other. It should be noted that prediction of NFA binding sites in the big GlyR proteins would be hardly possible in a purely theoretical study. It is the experimental data on the mutational analysis of the pore-lining residue, the Hill coefficients of NFA action and the depth of the NFA binding sites revealed by the Woodhull analysis that provided strong experimental constraints to elaborate structural models of NFA action in &#x003B1;1 and &#x003B1;2 GlyRs.</p>
<p>In conclusion, several results of our study evidence in favor of the pore-blocking mode of NFA action on glycine receptors: (i) the voltage dependence of the block; (ii) increase of the &#x003B1;1 GlyR blocking efficacy with the increased glycine concentration; (iii) appearance of high frequency interburst flickering upon NFA application revealed by single channel recordings, and (iv) mutation G254A in the TM2 segment of &#x003B1;1 subunit increased the receptors sensitivity to NFA. Molecular modeling provided a possible structural rationale for our experimental observations and suggested several blocking sites of NFA with preferable sites between levels 2&#x02032; and 9&#x02032; in &#x003B1;2 GlyR and between levels 9&#x02032; and 13&#x02032; in &#x003B1;1 GlyR.</p>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>GM and PB designed carried out and analyzed all patch clamp experiments, FP produced mutagenesis of glycine receptor and BZ performed molecular modeling.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack><p>We are grateful to Drs. H. Betz, C-M. Becker, and C. Villman for kind gifts of the cDNAs of the &#x003B1; and &#x003B2; subunits of GlyR. Computations were made possible by the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET). This study was supported for GM by a Fellowship from the French Ministry of Foreign Affairs and ERA SynBIO grant (MODULIGHTOR). BZ was supported by grants from the Russian Foundation for Basic Research (17-04-00549) and the Natural Sciences and Engineering Research Council of Canada (GRPIN-2014-04894).</p>
</ack>
<sec sec-type="supplementary-material" id="s6">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fnmol.2017.00125/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fnmol.2017.00125/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image1.jpeg" id="SM1" mimetype="image/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 1</label>
<caption><p><bold>Representative traces of single channel currents from &#x003B1;2 GlyRs recorded in outside-out configuration of patch-clamp technique evoked by 5 &#x003BC;M of glycine (A)</bold>, by mixture of 5 &#x003BC;M glycine&#x0002B;30 &#x003BC;M of NFA <bold>(B)</bold> and by glycine 5 &#x003BC;M&#x0002B;NFA 100 &#x003BC;M <bold>(C)</bold>; V<sub>hold</sub> &#x02212;30 mV.</p></caption></supplementary-material>
<supplementary-material xlink:href="Image2.jpeg" id="SM2" mimetype="image/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 2</label>
<caption><p><bold>IC<sub>50</sub> curves for NFA at &#x02212;80, &#x02212;30, &#x0002B;30, and &#x0002B;80 mV obtained from current-voltage dependencies recorded during application of mixture of glycine with different NFA concentrations. (A)</bold> Representative NFA IC<sub>50</sub> curves for currents mediated by &#x003B1;1 GlyRs, induced by 30 &#x003BC;M of glycine; NFA IC<sub>50</sub> at &#x02212;80 mV &#x0003D; 272 &#x003BC;M, &#x02212;30 mV &#x0003D; 256 &#x003BC;M, &#x0002B;30 mV &#x0003D; 218 &#x003BC;M, &#x0002B;80 mV &#x0003D; 178 &#x003BC;M. <bold>(B)</bold> Representative NFA IC<sub>50</sub> curves for currents mediated by &#x003B1;1 GlyRs, induced by 100 &#x003BC;M of glycine; NFA IC<sub>50</sub> at &#x02212;80 mV &#x0003D; 209 &#x003BC;M, &#x02212;30 mV &#x0003D; 171 &#x003BC;M, &#x0002B;30 mV &#x0003D; 107 &#x003BC;M, &#x0002B;80 mV &#x0003D; 94 &#x003BC;M. <bold>(C)</bold> Representative NFA IC<sub>50</sub> curves for currents mediated by &#x003B1;1&#x003B2; GlyRs, induced by 30 &#x003BC;M of glycine; NFA IC<sub>50</sub> at &#x02212;80 mV &#x0003D; 191 &#x003BC;M, &#x02212;30 mV &#x0003D; 200 &#x003BC;M, &#x0002B;30 mV &#x0003D; 152 &#x003BC;M, &#x0002B;80 mV &#x0003D; 144 &#x003BC;M. <bold>(D)</bold> Representative NFA IC<sub>50</sub> curves for currents mediated by &#x003B1;2 GlyRs, induced by 30 &#x003BC;M of glycine; NFA IC<sub>50</sub> at &#x02212;80 mV &#x0003D; 155 &#x003BC;M, &#x02212;30 mV &#x0003D; 75 &#x003BC;M, &#x0002B;30 mV &#x0003D; 17 &#x003BC;M, &#x0002B;80 mV &#x0003D; 12 &#x003BC;M. <bold>(E)</bold> Representative NFA IC<sub>50</sub> curves for currents mediated by &#x003B1;2 GlyRs, induced by 100 &#x003BC;M of glycine; NFA IC<sub>50</sub> at &#x02212;80 mV &#x0003D; 100 &#x003BC;M, &#x02212;30 mV &#x0003D; 39 &#x003BC;M, &#x0002B;30 mV &#x0003D; 12 &#x003BC;M, &#x0002B;80 mV &#x0003D; 7 &#x003BC;M. <bold>(F)</bold> Representative NFA IC<sub>50</sub> curves for currents mediated by &#x003B1;2&#x003B2; GlyRs, induced by 30 &#x003BC;M of glycine; NFA IC<sub>50</sub> at &#x02212;80 mV &#x0003D; 84 &#x003BC;M, &#x02212;30 mV &#x0003D; 47 &#x003BC;M, &#x0002B;30 mV &#x0003D; 24 &#x003BC;M, &#x0002B;80 mV &#x0003D; 22 &#x003BC;M. <bold>(G)</bold> Representative NFA IC<sub>50</sub> curves for currents mediated by &#x003B1;3 GlyRs, induced by 100 &#x003BC;M of glycine; NFA IC<sub>50</sub> at &#x02212;80 mV &#x0003D; 117 &#x003BC;M, &#x02212;30 mV &#x0003D; 78 &#x003BC;M, &#x0002B;30 mV &#x0003D; 23 &#x003BC;M, &#x0002B;80 mV &#x0003D; 10 &#x003BC;M. <bold>(H)</bold> Representative NFA IC<sub>50</sub> curves for currents mediated by &#x003B1;1 G254A GlyRs, induced by 30 &#x003BC;M of glycine; NFA IC<sub>50</sub> at &#x02212;80 mV &#x0003D; 230 &#x003BC;M, &#x02212;30 mV &#x0003D; 185 &#x003BC;M, &#x0002B;30 mV &#x0003D; 92 &#x003BC;M, &#x0002B;80 mV &#x0003D; 68 &#x003BC;M. <bold>(I)</bold> Representative NFA IC<sub>50</sub> curves for currents mediated by &#x003B1;1 G254A GlyRs, induced by 100 &#x003BC;M of glycine; NFA IC<sub>50</sub> at &#x02212;80 mV &#x0003D; 260 &#x003BC;M, &#x02212;30 mV &#x0003D; 190 &#x003BC;M, &#x0002B;30 mV &#x0003D; 106 &#x003BC;M, &#x0002B;80 mV &#x0003D; 57 &#x003BC;M.</p></caption></supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akaike</surname> <given-names>N.</given-names></name> <name><surname>Inoue</surname> <given-names>M.</given-names></name> <name><surname>Krishtal</surname> <given-names>O. A.</given-names></name></person-group> (<year>1986</year>). <article-title>&#x02018;Concentration-clamp&#x02019;study of gamma-aminobutyric-acid-induced chloride current kinetics in frog sensory neurones</article-title>. <source>J. Physiol.</source> <volume>379</volume>, <fpage>171</fpage>&#x02013;<lpage>185</lpage>. <pub-id pub-id-type="pmid">2435890</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnett</surname> <given-names>J.</given-names></name> <name><surname>Chow</surname> <given-names>J.</given-names></name> <name><surname>Ives</surname> <given-names>D.</given-names></name> <name><surname>Chiou</surname> <given-names>M.</given-names></name> <name><surname>Mackenzie</surname> <given-names>R.</given-names></name> <name><surname>Osen</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>1994</year>). <article-title>Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1209</volume>, <fpage>130</fpage>&#x02013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1016/0167-4838(94)90148-1</pub-id></citation>
</ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Betz</surname> <given-names>H.</given-names></name></person-group> (<year>1990</year>). <article-title>Ligand-gated ion channels in the brain: the amino acid receptor superfamily</article-title>. <source>Neuron</source> <volume>5</volume>, <fpage>383</fpage>&#x02013;<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(90)90077-S</pub-id><pub-id pub-id-type="pmid">1698394</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Betz</surname> <given-names>H.</given-names></name> <name><surname>Laube</surname> <given-names>B.</given-names></name></person-group> (<year>2006</year>). <article-title>Glycine receptors: recent insights into their structural organization and functional diversity</article-title>. <source>J. Neurochem.</source> <volume>97</volume>, <fpage>1600</fpage>&#x02013;<lpage>1610</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.03908.x</pub-id><pub-id pub-id-type="pmid">16805771</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanpied</surname> <given-names>T. A.</given-names></name> <name><surname>Clarke</surname> <given-names>R. J.</given-names></name> <name><surname>Johnson</surname> <given-names>J. W.</given-names></name></person-group> (<year>2005</year>). <article-title>Amantadine inhibits NMDA receptors by accelerating channel closure during channel block</article-title>. <source>J. Neurosci.</source> <volume>25</volume>, <fpage>3312</fpage>&#x02013;<lpage>3322</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4262-04.2005</pub-id><pub-id pub-id-type="pmid">15800186</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bormann</surname> <given-names>J.</given-names></name> <name><surname>Hamill</surname> <given-names>O. P.</given-names></name> <name><surname>Sakmann</surname> <given-names>B.</given-names></name></person-group> (<year>1987</year>). <article-title>Mechanism of anion permeation through channels gated by glycine and gamma-aminobutyric acid in mouse cultured spinal neurones</article-title>. <source>J. Physiol.</source> <volume>385</volume>, <fpage>243</fpage>&#x02013;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1987.sp016493</pub-id><pub-id pub-id-type="pmid">2443667</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bormann</surname> <given-names>J.</given-names></name> <name><surname>Rundstr&#x000F6;m</surname> <given-names>N.</given-names></name> <name><surname>Betz</surname> <given-names>H.</given-names></name> <name><surname>Langosch</surname> <given-names>D.</given-names></name></person-group> (<year>1993</year>). <article-title>Residues within transmembrane segment M2 determine chloride conductance of glycine receptor homo-and hetero-oligomers</article-title>. <source>EMBO J.</source> <volume>12</volume>, <fpage>3729</fpage>. <pub-id pub-id-type="pmid">8404844</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breitinger</surname> <given-names>H. G.</given-names></name> <name><surname>Lanig</surname> <given-names>H.</given-names></name> <name><surname>Vohwinkel</surname> <given-names>C.</given-names></name> <name><surname>Grewer</surname> <given-names>C.</given-names></name> <name><surname>Breitinger</surname> <given-names>U.</given-names></name> <name><surname>Clark</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Molecular dynamics simulation links conformation of a pore-flanking region to hyperekplexia-related dysfunction of the inhibitory glycine receptor</article-title>. <source>Chem. Biol.</source> <volume>11</volume>, <fpage>1339</fpage>&#x02013;<lpage>1350</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2004.07.008</pub-id><pub-id pub-id-type="pmid">15489161</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bristow</surname> <given-names>D. R.</given-names></name> <name><surname>Bowery</surname> <given-names>N. G.</given-names></name> <name><surname>Woodruff</surname> <given-names>G. N.</given-names></name></person-group> (<year>1986</year>). <article-title>Light microscopic autoradiographic localisation of [3H]glycine and [3H]strychnine binding sites in rat brain</article-title>. <source>Eur. J. Pharmacol.</source> <volume>126</volume>, <fpage>303</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(86)90062-2</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruhova</surname> <given-names>I.</given-names></name> <name><surname>Tikhonov</surname> <given-names>D. B.</given-names></name> <name><surname>Zhorov</surname> <given-names>B. S.</given-names></name></person-group> (<year>2008</year>). <article-title>Access and binding of local anesthetics in the closed sodium channel</article-title>. <source>Mol. Pharmacol.</source> <volume>74</volume>, <fpage>1033</fpage>&#x02013;<lpage>1045</lpage>. <pub-id pub-id-type="doi">10.1124/mol.108.049759</pub-id><pub-id pub-id-type="pmid">18653802</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruhova</surname> <given-names>I.</given-names></name> <name><surname>Zhorov</surname> <given-names>B. S.</given-names></name></person-group> (<year>2010</year>). <article-title>A homology model of the pore domain of a voltage-gated calcium channel is consistent with available SCAM data</article-title>. <source>J. Gen. Physiol.</source> <volume>135</volume>, <fpage>261</fpage>&#x02013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200910288</pub-id><pub-id pub-id-type="pmid">20176854</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cremonesi</surname> <given-names>G.</given-names></name> <name><surname>Cavalieri</surname> <given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation</article-title>. <source>J. Int. Med. Res.</source> <volume>43</volume>, <fpage>290</fpage>&#x02013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1177/0300060514567212</pub-id><pub-id pub-id-type="pmid">25921871</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>David-Watine</surname> <given-names>B.</given-names></name> <name><surname>Goblet</surname> <given-names>C.</given-names></name> <name><surname>de Saint Jan</surname> <given-names>D.</given-names></name> <name><surname>Fucile</surname> <given-names>S.</given-names></name> <name><surname>Devignot</surname> <given-names>V.</given-names></name> <name><surname>Bregestovski</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>1999</year>). <article-title>Cloning, expression and electrophysiological characterization of glycine receptor alpha subunit from zebrafish</article-title>. <source>Neuroscience</source> <volume>90</volume>, <fpage>303</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(98)00430-8</pub-id><pub-id pub-id-type="pmid">10188956</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Downie</surname> <given-names>D. L.</given-names></name> <name><surname>Hall</surname> <given-names>A. C.</given-names></name> <name><surname>Lieb</surname> <given-names>W. R.</given-names></name> <name><surname>Franks</surname> <given-names>N. P.</given-names></name></person-group> (<year>1996</year>). <article-title>Effects of inhalational general anaesthetics on native glycine receptors in rat medullary neurones and recombinant glycine receptors in Xenopus oocytes</article-title>. <source>Br. J. Pharmacol.</source> <volume>118</volume>, <fpage>493</fpage>&#x02013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1996.tb15430.x</pub-id><pub-id pub-id-type="pmid">8762070</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>J.</given-names></name> <name><surname>Lu</surname> <given-names>W.</given-names></name> <name><surname>Wu</surname> <given-names>S.</given-names></name> <name><surname>Cheng</surname> <given-names>Y.</given-names></name> <name><surname>Gouaux</surname> <given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Glycine receptor mechanism elucidated by electron cryo-microscopy</article-title>. <source>Nature</source> <volume>526</volume>, <fpage>224</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1038/nature14853</pub-id><pub-id pub-id-type="pmid">26344198</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dutertre</surname> <given-names>S.</given-names></name> <name><surname>Becker</surname> <given-names>C. M.</given-names></name> <name><surname>Betz</surname> <given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Inhibitory glycine receptors: an update</article-title>. <source>J. Biol. Chem.</source> <volume>287</volume>, <fpage>40216</fpage>&#x02013;<lpage>40223</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R112.408229</pub-id><pub-id pub-id-type="pmid">23038260</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frostholm</surname> <given-names>A.</given-names></name> <name><surname>Rotter</surname> <given-names>A.</given-names></name></person-group> (<year>1985</year>). <article-title>Glycine receptor distribution in mouse CNS: autoradiographic localization of [3H]strychnine binding sites</article-title>. <source>Brain Res. Bull.</source> <volume>15</volume>, <fpage>473</fpage>&#x02013;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1016/0361-9230(85)90038-3</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fucile</surname> <given-names>S.</given-names></name> <name><surname>de Saint Jan</surname> <given-names>D.</given-names></name> <name><surname>David-Watine</surname> <given-names>B.</given-names></name> <name><surname>Korn</surname> <given-names>H.</given-names></name> <name><surname>Bregestovski</surname> <given-names>P.</given-names></name></person-group> (<year>1999</year>). <article-title>Comparison of glycine and GABA actions on the zebrafish homomeric glycine receptor</article-title>. <source>J. Physiolo.</source> <volume>517</volume>(<issue>Pt 2</issue>), <fpage>369</fpage>&#x02013;<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.1999.0369t.x</pub-id><pub-id pub-id-type="pmid">10332088</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Alcocer</surname> <given-names>G.</given-names></name> <name><surname>Mejia</surname> <given-names>C.</given-names></name> <name><surname>Berumen</surname> <given-names>L. C.</given-names></name> <name><surname>Miledi</surname> <given-names>R.</given-names></name> <name><surname>Martinez-Torres</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Developmental expression of glycine receptor subunits in rat cerebellum</article-title>. <source>Int. J. Dev. Neurosci.</source> <volume>26</volume>, <fpage>319</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2008.01.005</pub-id><pub-id pub-id-type="pmid">18339511</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garden</surname> <given-names>D. P.</given-names></name> <name><surname>Zhorov</surname> <given-names>B. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Docking flexible ligands in proteins with a solvent exposure- and distance-dependent dielectric function</article-title>. <source>J. Comput. Aided Mol. Des.</source> <volume>24</volume>, <fpage>91</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-009-9317-9</pub-id><pub-id pub-id-type="pmid">20119653</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grenningloh</surname> <given-names>G.</given-names></name> <name><surname>Rienitz</surname> <given-names>A.</given-names></name> <name><surname>Schmitt</surname> <given-names>B.</given-names></name> <name><surname>Methfessel</surname> <given-names>C.</given-names></name> <name><surname>Zensen</surname> <given-names>M.</given-names></name> <name><surname>Beyreuther</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>1987</year>). <article-title>The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors</article-title>. <source>Nature</source> <volume>328</volume>, <fpage>215</fpage>&#x02013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1038/328215a0</pub-id><pub-id pub-id-type="pmid">3037383</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grenningloh</surname> <given-names>G.</given-names></name> <name><surname>Schmieden</surname> <given-names>V.</given-names></name> <name><surname>Schofield</surname> <given-names>P. R.</given-names></name> <name><surname>Seeburg</surname> <given-names>P. H.</given-names></name> <name><surname>Siddigue</surname> <given-names>T.</given-names></name> <name><surname>Mohandas</surname> <given-names>T. K.</given-names></name> <etal/></person-group>. (<year>1990</year>). <article-title>Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes</article-title>. <source>EMBO J.</source> <volume>9</volume>, <fpage>771</fpage>&#x02013;<lpage>776</lpage>. <pub-id pub-id-type="pmid">2155780</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>A. C.</given-names></name> <name><surname>Turcotte</surname> <given-names>C. M.</given-names></name> <name><surname>Betts</surname> <given-names>B. A.</given-names></name> <name><surname>Yeung</surname> <given-names>W. Y.</given-names></name> <name><surname>Agyeman</surname> <given-names>A. S.</given-names></name> <name><surname>Burk</surname> <given-names>L. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Modulation of human GABAA and glycine receptor currents by menthol and related monoterpenoids</article-title>. <source>Eur. J. Pharmacol.</source> <volume>506</volume>, <fpage>9</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2004.10.026</pub-id></citation>
</ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname> <given-names>R. J.</given-names></name> <name><surname>Depner</surname> <given-names>U. B.</given-names></name> <name><surname>Wassle</surname> <given-names>H.</given-names></name> <name><surname>Ahmadi</surname> <given-names>S.</given-names></name> <name><surname>Heindl</surname> <given-names>C.</given-names></name> <name><surname>Reinhold</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization</article-title>. <source>Science</source> <volume>304</volume>, <fpage>884</fpage>&#x02013;<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1126/science.1094925</pub-id><pub-id pub-id-type="pmid">15131310</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haverkamp</surname> <given-names>S.</given-names></name> <name><surname>Muller</surname> <given-names>U.</given-names></name> <name><surname>Zeilhofer</surname> <given-names>H. U.</given-names></name> <name><surname>Harvey</surname> <given-names>R.</given-names></name> <name><surname>Wassle</surname> <given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>Diversity of glycine receptors in the mouse retina: localization of the alpha3 subunit</article-title>. <source>J. Comp. Neurol.</source> <volume>465</volume>, <fpage>524</fpage>&#x02013;<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1002/cne.10852</pub-id><pub-id pub-id-type="pmid">12975813</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huanosta-Gutierrez</surname> <given-names>A.</given-names></name> <name><surname>Espino-Saldana</surname> <given-names>A. E.</given-names></name> <name><surname>Reyes</surname> <given-names>J. P.</given-names></name> <name><surname>Petriz</surname> <given-names>A.</given-names></name> <name><surname>Miledi</surname> <given-names>R.</given-names></name> <name><surname>Martinez-Torres</surname> <given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>TMEM16A alternative splicing isoforms in Xenopus tropicalis: distribution and functional properties</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>446</volume>, <fpage>1096</fpage>&#x02013;<lpage>1101</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2014.03.057</pub-id><pub-id pub-id-type="pmid">24661876</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imboden</surname> <given-names>M.</given-names></name> <name><surname>De Saint Jan</surname> <given-names>D.</given-names></name> <name><surname>Leulier</surname> <given-names>F.</given-names></name> <name><surname>Korn</surname> <given-names>H.</given-names></name> <name><surname>Goblet</surname> <given-names>C.</given-names></name> <name><surname>Bregestovski</surname> <given-names>P.</given-names></name></person-group> (<year>2001</year>). <article-title>Isolation and characterization of an alpha 2-type zebrafish glycine receptor subunit</article-title>. <source>Neuroscience</source> <volume>103</volume>, <fpage>799</fpage>&#x02013;<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(00)00575-3</pub-id><pub-id pub-id-type="pmid">11274795</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname> <given-names>R.</given-names></name> <name><surname>Lynch</surname> <given-names>J. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Mechanism of action of the insecticides, lindane and fipronil, on glycine receptor chloride channels</article-title>. <source>Br. J. Pharmacol.</source> <volume>165</volume>, <fpage>2707</fpage>&#x02013;<lpage>2720</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01722.x</pub-id><pub-id pub-id-type="pmid">22035056</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jabeen</surname> <given-names>T.</given-names></name> <name><surname>Singh</surname> <given-names>N.</given-names></name> <name><surname>Sharma</surname> <given-names>S.</given-names></name> <name><surname>Somvanshi</surname> <given-names>R. K.</given-names></name> <name><surname>Dey</surname> <given-names>S.</given-names></name> <name><surname>Singh</surname> <given-names>T. P.</given-names></name></person-group> (<year>2005</year>). <article-title>Non-steroidal anti-inflammatory drugs as potent inhibitors of phospholipase A2: structure of the complex of phospholipase A2 with niflumic acid at 2.5 Angstroms resolution</article-title>. <source>Acta Crystallogr. Sect. D Biol. Crystallogr.</source> <volume>61</volume>(<issue>Pt 12</issue>), <fpage>1579</fpage>&#x02013;<lpage>1586</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444905029604</pub-id><pub-id pub-id-type="pmid">16301791</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>J. L.</given-names></name> <name><surname>Wimsatt</surname> <given-names>J.</given-names></name> <name><surname>Buckel</surname> <given-names>S. D.</given-names></name> <name><surname>Dyer</surname> <given-names>R. D.</given-names></name> <name><surname>Maddipati</surname> <given-names>K. R.</given-names></name></person-group> (<year>1995</year>). <article-title>Purification and characterization of prostaglandin H synthase-2 from sheep placental cotyledons</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>324</volume>, <fpage>26</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1006/abbi.1995.9934</pub-id><pub-id pub-id-type="pmid">7503555</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>W.</given-names></name> <name><surname>Kim</surname> <given-names>K.</given-names></name> <name><surname>Kim</surname> <given-names>E. Y.</given-names></name> <name><surname>Kwon</surname> <given-names>K. I.</given-names></name> <name><surname>Bang</surname> <given-names>J. S.</given-names></name> <name><surname>Yoon</surname> <given-names>Y. R.</given-names></name></person-group> (<year>2008</year>). <article-title>Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate</article-title>. <source>Eur. J. Clin. Pharmacol.</source> <volume>64</volume>, <fpage>1027</fpage>&#x02013;<lpage>1030</lpage>. <pub-id pub-id-type="doi">10.1007/s00228-008-0524-4</pub-id><pub-id pub-id-type="pmid">18607579</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kondratskaya</surname> <given-names>E. L.</given-names></name> <name><surname>Betz</surname> <given-names>H.</given-names></name> <name><surname>Krishtal</surname> <given-names>O. A.</given-names></name> <name><surname>Laube</surname> <given-names>B.</given-names></name></person-group> (<year>2005</year>). <article-title>The beta subunit increases the ginkgolide B sensitivity of inhibitory glycine receptors</article-title>. <source>Neuropharmacology</source> <volume>49</volume>, <fpage>945</fpage>&#x02013;<lpage>951</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2005.07.001</pub-id><pub-id pub-id-type="pmid">16125206</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lantz</surname> <given-names>B.</given-names></name> <name><surname>Cochat</surname> <given-names>P.</given-names></name> <name><surname>Bouchet</surname> <given-names>J. L.</given-names></name> <name><surname>Fischbach</surname> <given-names>M.</given-names></name></person-group> (<year>1994</year>). <article-title>Short-term niflumic-acid-induced acute renal failure in children</article-title>. <source>Nephrol. Dial. Transpl.</source> <volume>9</volume>, <fpage>1234</fpage>&#x02013;<lpage>1239</lpage>. <pub-id pub-id-type="pmid">7816282</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lautenschlager</surname> <given-names>P.</given-names></name> <name><surname>Brickmann</surname> <given-names>J.</given-names></name></person-group> (<year>1991</year>). <article-title>Conformations and rotational barriers of aromatic polyesters</article-title>. <source>Macromolecules</source> <volume>24</volume>, <fpage>1284</fpage>&#x02013;<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1021/ma00006a012</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Z.</given-names></name> <name><surname>Scheraga</surname> <given-names>H. A.</given-names></name></person-group> (<year>1987</year>). <article-title>Monte Carlo-minimization approach to the multiple-minima problem in protein folding</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>84</volume>, <fpage>6611</fpage>&#x02013;<lpage>6615</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.84.19.6611</pub-id><pub-id pub-id-type="pmid">3477791</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liantonio</surname> <given-names>A.</given-names></name> <name><surname>Giannuzzi</surname> <given-names>V.</given-names></name> <name><surname>Picollo</surname> <given-names>A.</given-names></name> <name><surname>Babini</surname> <given-names>E.</given-names></name> <name><surname>Pusch</surname> <given-names>M.</given-names></name> <name><surname>Conte Camerino</surname> <given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium</article-title>. <source>Br. J. Pharmacol.</source> <volume>150</volume>, <fpage>235</fpage>&#x02013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0706954</pub-id><pub-id pub-id-type="pmid">17128287</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lynagh</surname> <given-names>T.</given-names></name> <name><surname>Pless</surname> <given-names>S. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Principles of agonist recognition in Cys-loop receptors</article-title>. <source>Front. Physiol.</source> <volume>5</volume>:<fpage>160</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00160</pub-id><pub-id pub-id-type="pmid">24795655</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lynagh</surname> <given-names>T.</given-names></name> <name><surname>Webb</surname> <given-names>T. I.</given-names></name> <name><surname>Dixon</surname> <given-names>C. L.</given-names></name> <name><surname>Cromer</surname> <given-names>B. A.</given-names></name> <name><surname>Lynch</surname> <given-names>J. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel</article-title>. <source>J. Biol. Chem.</source> <volume>286</volume>, <fpage>43913</fpage>&#x02013;<lpage>43924</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.262634</pub-id><pub-id pub-id-type="pmid">22033924</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname> <given-names>J. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Molecular structure and function of the glycine receptor chloride channel</article-title>. <source>Physiol. Rev.</source> <volume>84</volume>, <fpage>1051</fpage>&#x02013;<lpage>1095</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00042.2003</pub-id></citation>
</ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname> <given-names>J. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Native glycine receptor subtypes and their physiological roles</article-title>. <source>Neuropharmacology</source> <volume>56</volume>, <fpage>303</fpage>&#x02013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.07.034</pub-id><pub-id pub-id-type="pmid">18721822</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maleeva</surname> <given-names>G.</given-names></name> <name><surname>Buldakova</surname> <given-names>S.</given-names></name> <name><surname>Bregestovski</surname> <given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Selective potentiation of alpha 1 glycine receptors by ginkgolic acid</article-title>. <source>Front. Mol. Neurosci.</source> <volume>8</volume>:<fpage>64</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2015.00064</pub-id><pub-id pub-id-type="pmid">26578878</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manach</surname> <given-names>Y.</given-names></name> <name><surname>Ditisheim</surname> <given-names>A.</given-names></name></person-group> (<year>1990</year>). <article-title>Double-blind, placebo-controlled multicentre trial of the efficacy and tolerance of morniflumate suppositories in the treatment of tonsillitis in children</article-title>. <source>J. Int. Med. Res.</source> <volume>18</volume>, <fpage>30</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1177/030006059001800105</pub-id><pub-id pub-id-type="pmid">2110537</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mascia</surname> <given-names>M. P.</given-names></name> <name><surname>Machu</surname> <given-names>T. K.</given-names></name> <name><surname>Harris</surname> <given-names>R. A.</given-names></name></person-group> (<year>1996</year>). <article-title>Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics</article-title>. <source>Br. J. Pharmacol.</source> <volume>119</volume>, <fpage>1331</fpage>&#x02013;<lpage>1336</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1996.tb16042.x</pub-id><pub-id pub-id-type="pmid">8968539</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCarberg</surname> <given-names>B.</given-names></name> <name><surname>Gibofsky</surname> <given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Need to develop new nonsteroidal anti-inflammatory drug formulations</article-title>. <source>Clin. Ther.</source> <volume>34</volume>, <fpage>1954</fpage>&#x02013;<lpage>1963</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinthera.2012.08.005</pub-id></citation>
</ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mero</surname> <given-names>F.</given-names></name> <name><surname>Nettis</surname> <given-names>E.</given-names></name> <name><surname>Aloia</surname> <given-names>A. M.</given-names></name> <name><surname>Di Leo</surname> <given-names>E.</given-names></name> <name><surname>Ferrannini</surname> <given-names>A.</given-names></name> <name><surname>Vacca</surname> <given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Short-term tolerability of morniflumate in patients with cutaneous hypersensitivity reactions to non-steroidal anti-inflammatory drugs</article-title>. <source>Int. J. Immunopathol. Pharmacol.</source> <volume>26</volume>, <fpage>247</fpage>&#x02013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1177/039463201302600126</pub-id><pub-id pub-id-type="pmid">23527729</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>P. S.</given-names></name> <name><surname>Da Silva</surname> <given-names>H. M.</given-names></name> <name><surname>Smart</surname> <given-names>T. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Molecular basis for zinc potentiation at strychnine-sensitive glycine receptors</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume>, <fpage>37877</fpage>&#x02013;<lpage>37884</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M508303200</pub-id><pub-id pub-id-type="pmid">16144831</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>P. S.</given-names></name> <name><surname>Smart</surname> <given-names>T. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Binding, activation and modulation of Cys-loop receptors</article-title>. <source>Trends Pharmacol. Sci.</source> <volume>31</volume>, <fpage>161</fpage>&#x02013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2009.12.005</pub-id><pub-id pub-id-type="pmid">20096941</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname> <given-names>A.</given-names></name> <name><surname>Nguyen</surname> <given-names>Q. T.</given-names></name> <name><surname>Miledi</surname> <given-names>R.</given-names></name></person-group> (<year>1994</year>). <article-title>Electrophysiological properties of newborn and adult rat spinal cord glycine receptors expressed in Xenopus oocytes</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>91</volume>, <fpage>3097</fpage>&#x02013;<lpage>3101</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.91.8.3097</pub-id><pub-id pub-id-type="pmid">8159710</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mukhtarov</surname> <given-names>M.</given-names></name> <name><surname>Liguori</surname> <given-names>L.</given-names></name> <name><surname>Waseem</surname> <given-names>T.</given-names></name> <name><surname>Rocca</surname> <given-names>F.</given-names></name> <name><surname>Buldakova</surname> <given-names>S.</given-names></name> <name><surname>Arosio</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Calibration and functional analysis of three genetically encoded Cl(-)/pH sensors</article-title>. <source>Front. Mol. Neurosci.</source> <volume>6</volume>:<fpage>9</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2013.00009</pub-id><pub-id pub-id-type="pmid">23616745</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname> <given-names>H. M. K.</given-names></name> <name><surname>Vijayan</surname> <given-names>M.</given-names></name></person-group> (<year>1978</year>). <article-title>2- {[3-(Trifluoromethyl)phenyl]amino}- 3-pyridinecarbo xylic Acid (Niflumic Acid)</article-title>. <source>Acta Cryst.</source> <volume>B35</volume>, <fpage>262</fpage>&#x02013;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1107/S0567740879003253</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neher</surname> <given-names>E.</given-names></name> <name><surname>Steinbach</surname> <given-names>J. H.</given-names></name></person-group> (<year>1978</year>). <article-title>Local anaesthetics transiently block currents through single acetylcholine-receptor channels</article-title>. <source>J. Physiol.</source> <volume>277</volume>, <fpage>153</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1978.sp012267</pub-id><pub-id pub-id-type="pmid">306437</pub-id></citation></ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname> <given-names>Y. L.</given-names></name> <name><surname>Kuan</surname> <given-names>A. S.</given-names></name> <name><surname>Chen</surname> <given-names>T. Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Activation and inhibition of TMEM16A calcium-activated chloride channels</article-title>. <source>PLoS ONE</source> <volume>9</volume>:<fpage>e86734</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0086734</pub-id><pub-id pub-id-type="pmid">24489780</pub-id></citation></ref>
<ref id="B53">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nikolic</surname> <given-names>Z.</given-names></name> <name><surname>Laube</surname> <given-names>B.</given-names></name> <name><surname>Weber</surname> <given-names>R. G.</given-names></name> <name><surname>Lichter</surname> <given-names>P.</given-names></name> <name><surname>Kioshis</surname> <given-names>P.</given-names></name> <name><surname>Poustka</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>1998</year>). <article-title>The human glycine receptor subunit alpha3. Glra3 gene structure, chromosomal localization, and functional characterization of alternative transcripts</article-title>. <source>J. Biol. Chem.</source> <volume>273</volume>, <fpage>19708</fpage>&#x02013;<lpage>19714</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.31.19708</pub-id><pub-id pub-id-type="pmid">9677400</pub-id></citation></ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname> <given-names>L.</given-names></name> <name><surname>Bregestovski</surname> <given-names>P.</given-names></name> <name><surname>Ascher</surname> <given-names>P.</given-names></name> <name><surname>Herbet</surname> <given-names>A.</given-names></name> <name><surname>Prochiantz</surname> <given-names>A.</given-names></name></person-group> (<year>1984</year>). <article-title>Magnesium gates glutamate-activated channels in mouse central neurones</article-title>. <source>Nature</source> <volume>307</volume>, <fpage>462</fpage>&#x02013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1038/307462a0</pub-id><pub-id pub-id-type="pmid">6320006</pub-id></citation></ref>
<ref id="B55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pribilla</surname> <given-names>I.</given-names></name> <name><surname>Takagi</surname> <given-names>T.</given-names></name> <name><surname>Langosch</surname> <given-names>D.</given-names></name> <name><surname>Bormann</surname> <given-names>J.</given-names></name> <name><surname>Betz</surname> <given-names>H.</given-names></name></person-group> (<year>1992</year>). <article-title>The atypical M2 segment of the beta subunit confers picrotoxinin resistance to inhibitory glycine receptor channels</article-title>. <source>EMBO J.</source> <volume>11</volume>, <fpage>4305</fpage>&#x02013;<lpage>4311</lpage>. <pub-id pub-id-type="pmid">1385113</pub-id></citation></ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Probst</surname> <given-names>A.</given-names></name> <name><surname>Cortes</surname> <given-names>R.</given-names></name> <name><surname>Palacios</surname> <given-names>J. M.</given-names></name></person-group> (<year>1986</year>). <article-title>The distribution of glycine receptors in the human brain. A light microscopic autoradiographic study using [3H]strychnine</article-title>. <source>Neuroscience</source> <volume>17</volume>, <fpage>11</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(86)90222-8</pub-id></citation></ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname> <given-names>Z.</given-names></name> <name><surname>Hartzell</surname> <given-names>H. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Functional geometry of the permeation pathway of Ca<sup>2&#x0002B;</sup>-activated Cl-channels inferred from analysis of voltage-dependent block</article-title>. <source>J. Biol. Chem.</source> <volume>276</volume>, <fpage>18423</fpage>&#x02013;<lpage>18429</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M101264200</pub-id><pub-id pub-id-type="pmid">11279188</pub-id></citation></ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raltschev</surname> <given-names>C.</given-names></name> <name><surname>Hetsch</surname> <given-names>F.</given-names></name> <name><surname>Winkelmann</surname> <given-names>A.</given-names></name> <name><surname>Meier</surname> <given-names>J. C.</given-names></name> <name><surname>Semtner</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Electrophysiological signature of homomeric and heteromeric glycine receptor channels</article-title>. <source>J. Biol. Chem.</source> <volume>291</volume>, <fpage>18030</fpage>&#x02013;<lpage>18040</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.735084</pub-id><pub-id pub-id-type="pmid">27382060</pub-id></citation></ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname> <given-names>G. L.</given-names></name> <name><surname>Iwamoto</surname> <given-names>T.</given-names></name> <name><surname>Tomich</surname> <given-names>J. M.</given-names></name> <name><surname>Montal</surname> <given-names>M.</given-names></name></person-group> (<year>1993</year>). <article-title>Synthetic peptides and four-helix bundle proteins as model systems for the pore-forming structure of channel proteins. II. Transmembrane segment M2 of the brain glycine receptor is a plausible candidate for the pore-lining structure</article-title>. <source>J. Biol. Chem.</source> <volume>268</volume>, <fpage>14608</fpage>&#x02013;<lpage>14615</lpage>. <pub-id pub-id-type="pmid">7686901</pub-id></citation></ref>
<ref id="B60">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rundstrom</surname> <given-names>N.</given-names></name> <name><surname>Schmieden</surname> <given-names>V.</given-names></name> <name><surname>Betz</surname> <given-names>H.</given-names></name> <name><surname>Bormann</surname> <given-names>J.</given-names></name> <name><surname>Langosch</surname> <given-names>D.</given-names></name></person-group> (<year>1994</year>). <article-title>Cyanotriphenylborate: subtype-specific blocker of glycine receptor chloride channels</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>91</volume>, <fpage>8950</fpage>&#x02013;<lpage>8954</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.91.19.8950</pub-id><pub-id pub-id-type="pmid">8090751</pub-id></citation></ref>
<ref id="B61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x000E1;nchez</surname> <given-names>A.</given-names></name> <name><surname>Y&#x000E9;venes</surname> <given-names>G. E.</given-names></name> <name><surname>San Martin</surname> <given-names>L.</given-names></name> <name><surname>Burgos</surname> <given-names>C. F.</given-names></name> <name><surname>Moraga-Cid</surname> <given-names>G.</given-names></name> <name><surname>Harvey</surname> <given-names>R. J.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Control of ethanol sensitivity of the glycine receptor &#x003B1;3 subunit by transmembrane 2, the intracellular splice cassette and C-terminal domain</article-title>. <source>J. Pharmacol. Exp. Ther.</source> <volume>353</volume>, <fpage>80</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.114.221143</pub-id></citation></ref>
<ref id="B62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sauvage</surname> <given-names>J. P.</given-names></name> <name><surname>Ditisheim</surname> <given-names>A.</given-names></name> <name><surname>Bessede</surname> <given-names>J. P.</given-names></name> <name><surname>David</surname> <given-names>N.</given-names></name></person-group> (<year>1990</year>). <article-title>Double-blind, placebo-controlled, multi-centre trial of the efficacy and tolerance of niflumic acid (&#x02018;Nifluril&#x02019;) capsules in the treatment of tonsillitis in adults</article-title>. <source>Curr. Med. Res. Opin.</source> <volume>11</volume>, <fpage>631</fpage>&#x02013;<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1185/03007999009112689</pub-id><pub-id pub-id-type="pmid">2107060</pub-id></citation></ref>
<ref id="B63">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname> <given-names>N.</given-names></name> <name><surname>Vogel</surname> <given-names>N.</given-names></name> <name><surname>Villmann</surname> <given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation?</article-title> <source>Front. Mol. Neurosci.</source> <volume>5</volume>:<fpage>98</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2012.00098</pub-id><pub-id pub-id-type="pmid">23118727</pub-id></citation></ref>
<ref id="B64">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmieden</surname> <given-names>V.</given-names></name> <name><surname>Grenningloh</surname> <given-names>G.</given-names></name> <name><surname>Schofield</surname> <given-names>P. R.</given-names></name> <name><surname>Betz</surname> <given-names>H.</given-names></name></person-group> (<year>1989</year>). <article-title>Functional expression in Xenopus oocytes of the strychnine binding 48 kd subunit of the glycine receptor</article-title>. <source>EMBO J.</source> <volume>8</volume>:<fpage>695</fpage>. <pub-id pub-id-type="pmid">2470588</pub-id></citation></ref>
<ref id="B65">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname> <given-names>Q.</given-names></name> <name><surname>Haddrill</surname> <given-names>J. L.</given-names></name> <name><surname>Lynch</surname> <given-names>J. W.</given-names></name></person-group> (<year>2001</year>). <article-title>A single beta subunit M2 domain residue controls the picrotoxin sensitivity of alphabeta heteromeric glycine receptor chloride channels</article-title>. <source>J. Neurochem.</source> <volume>76</volume>, <fpage>1109</fpage>&#x02013;<lpage>1120</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00124.x</pub-id><pub-id pub-id-type="pmid">11181831</pub-id></citation></ref>
<ref id="B66">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sigel</surname> <given-names>E.</given-names></name> <name><surname>Steinmann</surname> <given-names>M. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Structure, function, and modulation of GABA(A) receptors</article-title>. <source>J. Biol. Chem.</source> <volume>287</volume>, <fpage>40224</fpage>&#x02013;<lpage>40231</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R112.386664</pub-id><pub-id pub-id-type="pmid">23038269</pub-id></citation></ref>
<ref id="B67">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sinkkonen</surname> <given-names>S. T.</given-names></name> <name><surname>Mansikkam&#x000E4;ki</surname> <given-names>S.</given-names></name> <name><surname>M&#x000F6;ykkynen</surname> <given-names>T.</given-names></name> <name><surname>L&#x000FC;ddens</surname> <given-names>H.</given-names></name> <name><surname>Uusi-Oukari</surname> <given-names>M.</given-names></name> <name><surname>Korpi</surname> <given-names>E. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug</article-title>. <source>Mol. Pharmacol.</source> <volume>64</volume>, <fpage>753</fpage>&#x02013;<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1124/mol.64.3.753</pub-id><pub-id pub-id-type="pmid">12920213</pub-id></citation></ref>
<ref id="B68">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>W. L.</given-names></name></person-group> (<year>1992</year>). <article-title>Prostanoid biosynthesis and mechanisms of action</article-title>. <source>Am. J. Physiol.</source> <volume>263</volume>, <fpage>F181</fpage>&#x02013;<lpage>F191</lpage>. <pub-id pub-id-type="pmid">1324603</pub-id></citation></ref>
<ref id="B69">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sturkenboom</surname> <given-names>M.</given-names></name> <name><surname>Nicolosi</surname> <given-names>A.</given-names></name> <name><surname>Cantarutti</surname> <given-names>L.</given-names></name> <name><surname>Mannino</surname> <given-names>S.</given-names></name> <name><surname>Picelli</surname> <given-names>G.</given-names></name> <name><surname>Scamarcia</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics</article-title>. <source>Pediatrics</source> <volume>116</volume>, <fpage>e26</fpage>&#x02013;<lpage>e33</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2004-0040</pub-id></citation></ref>
<ref id="B70">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname> <given-names>T.</given-names></name> <name><surname>Momiyama</surname> <given-names>A.</given-names></name> <name><surname>Hirai</surname> <given-names>K.</given-names></name> <name><surname>Hishinuma</surname> <given-names>F.</given-names></name> <name><surname>Akagi</surname> <given-names>H.</given-names></name></person-group> (<year>1992</year>). <article-title>Functional correlation of fetal and adult forms of glycine receptors with developmental changes in inhibitory synaptic receptor channels</article-title>. <source>Neuron</source> <volume>9</volume>, <fpage>1155</fpage>&#x02013;<lpage>1161</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(92)90073-M</pub-id><pub-id pub-id-type="pmid">1281418</pub-id></citation></ref>
<ref id="B71">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname> <given-names>C. M.</given-names></name> <name><surname>Laugel</surname> <given-names>C.</given-names></name> <name><surname>Marty</surname> <given-names>J. P.</given-names></name></person-group> (<year>1999</year>). <article-title><italic>In vitro</italic> topical delivery of non-steroidal anti-inflammatory drugs through human skin</article-title>. <source>Arzneimittelforschung.</source> <volume>49</volume>, <fpage>509</fpage>&#x02013;<lpage>513</lpage>.</citation>
</ref>
<ref id="B72">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>D. S.</given-names></name> <name><surname>Mangin</surname> <given-names>J. M.</given-names></name> <name><surname>Moonen</surname> <given-names>G.</given-names></name> <name><surname>Rigo</surname> <given-names>J. M.</given-names></name> <name><surname>Legendre</surname> <given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Mechanisms for picrotoxin block of alpha2 homomeric glycine receptors</article-title>. <source>J. Biol. Chem.</source> <volume>281</volume>, <fpage>3841</fpage>&#x02013;<lpage>3855</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M511022200</pub-id><pub-id pub-id-type="pmid">16344549</pub-id></citation></ref>
<ref id="B73">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>M. M.</given-names></name> <name><surname>Aylwin</surname> <given-names>M.</given-names></name></person-group> (<year>1990</year>). <article-title>Niflumic and flufenamic acids are potent reversible blockers of Ca<sup>2(&#x0002B;)</sup>-activated Cl<sup>&#x02212;</sup> channels in Xenopus oocytes</article-title>. <source>Mol. Pharmacol.</source> <volume>37</volume>, <fpage>720</fpage>&#x02013;<lpage>724</lpage>. <pub-id pub-id-type="pmid">1692608</pub-id></citation></ref>
<ref id="B74">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woodhull</surname> <given-names>A. M.</given-names></name></person-group> (<year>1973</year>). <article-title>Ionic blockage of sodium channels in nerve</article-title>. <source>J. Gen. Physiol.</source> <volume>61</volume>, <fpage>687</fpage>&#x02013;<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.61.6.687</pub-id><pub-id pub-id-type="pmid">4541078</pub-id></citation></ref>
<ref id="B75">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y. D.</given-names></name> <name><surname>Cho</surname> <given-names>H.</given-names></name> <name><surname>Koo</surname> <given-names>J. Y.</given-names></name> <name><surname>Tak</surname> <given-names>M. H.</given-names></name> <name><surname>Cho</surname> <given-names>Y.</given-names></name> <name><surname>Shim</surname> <given-names>W. S.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>TMEM16A confers receptor-activated calcium-dependent chloride conductance</article-title>. <source>Nature</source> <volume>455</volume>, <fpage>1210</fpage>&#x02013;<lpage>1215</lpage>. <pub-id pub-id-type="doi">10.1038/nature07313</pub-id><pub-id pub-id-type="pmid">18724360</pub-id></citation></ref>
<ref id="B76">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>A. B.</given-names></name> <name><surname>Snyder</surname> <given-names>S. H.</given-names></name></person-group> (<year>1973</year>). <article-title>Strychnine binding associated with glycine receptors of the central nervous system</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>70</volume>, <fpage>2832</fpage>&#x02013;<lpage>2836</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.70.10.2832</pub-id><pub-id pub-id-type="pmid">4200724</pub-id></citation></ref>
<ref id="B77">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X. B.</given-names></name> <name><surname>Sun</surname> <given-names>G. C.</given-names></name> <name><surname>Liu</surname> <given-names>L. Y.</given-names></name> <name><surname>Yu</surname> <given-names>F.</given-names></name> <name><surname>Xu</surname> <given-names>T. L.</given-names></name></person-group> (<year>2008</year>). <article-title>&#x003B1;2 subunit specificity of cyclothiazide inhibition on glycine receptors</article-title>. <source>Mol. Pharmacol.</source> <volume>73</volume>, <fpage>1195</fpage>&#x02013;<lpage>1202</lpage>. <pub-id pub-id-type="doi">10.1124/mol.107.042655</pub-id><pub-id pub-id-type="pmid">18162605</pub-id></citation></ref>
<ref id="B78">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zifarelli</surname> <given-names>G.</given-names></name> <name><surname>Liantonio</surname> <given-names>A.</given-names></name> <name><surname>Gradogna</surname> <given-names>A.</given-names></name> <name><surname>Picollo</surname> <given-names>A.</given-names></name> <name><surname>Gramegna</surname> <given-names>G.</given-names></name> <name><surname>De Bellis</surname></name> <etal/></person-group>. (<year>2010</year>). <article-title>Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels</article-title>. <source>Br. J. Pharmacol.</source> <volume>160</volume>, <fpage>1652</fpage>&#x02013;<lpage>1661</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2010.00822.x</pub-id><pub-id pub-id-type="pmid">20649569</pub-id></citation></ref>
<ref id="B79">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zifarelli</surname> <given-names>G.</given-names></name> <name><surname>Pusch</surname> <given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>CLC chloride channels and transporters: a biophysical and physiological perspective</article-title>. <source>Rev. Physiol. Biochem. Pharmacol.</source> <volume>158</volume>, <fpage>23</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1007/112_2006_0605</pub-id></citation>
</ref>
<ref id="B80">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuliani</surname> <given-names>L.</given-names></name> <name><surname>Ferlazzo</surname> <given-names>E.</given-names></name> <name><surname>Andrigo</surname> <given-names>C.</given-names></name> <name><surname>Casano</surname> <given-names>A.</given-names></name> <name><surname>Cianci</surname> <given-names>V.</given-names></name> <name><surname>Zoccarato</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy</article-title>. <source>Neurol. Neuroimmunol. Neuroinflamm.</source> <volume>1</volume>:<fpage>e16</fpage>. <pub-id pub-id-type="doi">10.1212/NXI.0000000000000016</pub-id><pub-id pub-id-type="pmid">25340068</pub-id></citation></ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>CNS</term>
<def><p>central nervous system</p></def></def-item>
<def-item><term>cry-EM</term>
<def><p>cryoelectron microscopy</p></def></def-item>
<def-item><term>GlyR</term>
<def><p>Glycine Receptor</p></def></def-item>
<def-item><term>NFA</term>
<def><p>Niflumic acid</p></def></def-item>
<def-item><term>MC</term>
<def><p>Monte Carlo</p></def></def-item>
<def-item><term>MCM</term>
<def><p>Monte Carlo energy minimization</p></def></def-item>
<def-item><term>MP</term>
<def><p>membrane potential</p></def></def-item>
<def-item><term>V<sub>hold</sub></term>
<def><p>holding potential.</p></def></def-item>
</def-list>
</glossary>
</back>
</article>
